Abstract
K+ channels enable potassium to flow across the membrane with great selectivity. There are four K+ channel families: voltage-gated K (Kv), calcium-activated (KCa), inwardly rectifying K (Kir), and two-pore domain potassium (K2P) channels. All four K+ channels are formed by subunits assembling into a classic tetrameric (4x1P = 4P for the Kv, KCa, and Kir channels) or tetramer-like (2x2P = 4P for the K2P channels) architecture. These subunits can either be the same (homomers) or different (heteromers), conferring great diversity to these channels. They share a highly conserved selectivity filter within the pore but show different gating mechanisms adapted for their function. K+ channels play essential roles in controlling neuronal excitability by shaping action potentials, influencing the resting membrane potential, and responding to diverse physicochemical stimuli, such as a voltage change (Kv), intracellular calcium oscillations (KCa), cellular mediators (Kir), or temperature (K2P).
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Calcium-activated
- Conductivity
- Gating
- Inwardly rectifying K
- Ion channel
- Potassium channel
- Selectivity
- Two-pore domain potassium
- Voltage-gated K
1 Overview
A key property of all K+ channels is their ability to selectively allow permeation of K+ across the membrane at near diffusion limited rates. That is, they discriminate between K+ and other monovalent cations and anions, with high fidelity, providing a conduit for K+ to flow in and out of cells. Built on the framework of K+ selectivity, K+ channels have evolved different gating mechanisms (i.e., opening and closing) and functions in a variety of cell types. In this chapter, we compare some of the essential features of K+ channels across the different families and subfamilies.
The voltage-gated K+ channels (Kv) form the largest gene family in the K+ channel group, first described by Hodgkin and Huxley (1945) and cloned 36 years ago (Noda et al. 1984). In mammals, Kv channels are encoded by 40 genes, with each gene encoding a corresponding α subunit. Traditionally, Kv channels play a role in cell excitability, where channel opening helps to repolarize excitable cells via efflux of K+, such as during the action potential (Hille 1986). The Kv channel family is divided into 12 subfamilies (A-González and Castrillo 2011; Abbott et al. 2001) (Fig. 1), based on analyses of the hydrophobic domain containing the six transmembrane segments (S1-S6).
The first evidence of K+ currents activated by calcium was described by Gardos over 60 years ago, who observed the activation of K+ selective conductance by intracellular free calcium in red blood cells (Gardos 1958). The family of calcium-activated (KCa) channels encompasses a group of K+ channels with different physiological and pharmacological properties. The calcium sensitivity characteristic of KCa channels allows them to couple membrane potential changes during the action potential with elevations in intracellular Ca2+ concentration ([Ca2+]i), contributing to activation of the afterhyperpolarization (AHP) and regulation of the action potential (Berkefeld et al. 2010). Based on their single-channel conductance, KCa channels can be classified as small conductance (SK) KCa channels, which are KCa2.1-KCa2.3 (4–14 pS) (Kohler et al. 1996), intermediate conductance (IK) KCa channel, also named as KCa3.1 (32–39 pS) (Ishii et al. 1997), and large conductance (big conductance, BK) KCa channel, also known as KCa1.1 or Slo1 (200–300 pS) (Butler et al. 1993; Kshatri et al. 2018). With a fair degree of sequence homology, the KCa channel family includes the sodium-activated K+ channels KCa4.1 and KCa4.2 (also called Slack/Slo2.1 and Slick/Slo2.2, respectively), as well as the pH-dependent KCa5.1 channels (also named as Slo3) (Fig. 1) (Wei et al. 2005).
Inwardly rectifying K (Kir) channels were first described over 70 years ago in skeletal muscle fibers by Bernard Katz (1949), who observed an “anomalous” rectifier inward current in the presence of different extracellular K+ concentrations. Kir gating appeared to shift with the Nernst potential for K+. Years later, several studies explained that the property of inward rectification arises from an asymmetric blockade of the open channel pore by intracellular Mg2+ (Matsuda et al. 1987) and polyamines (Lopatin et al. 1994; Oliver et al. 2000). This property of inward rectification enables Kir channels to play a key role in the maintenance of the resting membrane potential and the regulation of the action potential duration in excitable cells (Hibino et al. 2010). The family of inwardly rectifying K+ channels comprises a variety of channels classified in seven different subfamilies, from Kir1.x to Kir7.1 (Kubo et al. 2005) that are encoded by 15 different genes (Kubo et al. 2005) (Fig. 1). From a functional perspective, Kir channels can be classified into four groups: (1) K+ transport channels, including Kir1.1, Kir4.1-Kir4.2, Kir5.1, and Kir7.1; (2) Classical Kir channels, comprising Kir2.1-Kir2.4 channels; (3) Kir3.x or G-protein-gated Kir channels (GIRK), which encompass GIRK1–4; and (4) ATP-sensitive K+ channels (KATP), which correspond to Kir6.1-Kir6.2 (Hibino et al. 2010; Kubo et al. 2005). Due to their divergence in properties from other Kir channels, some are often referred to by their functional name, i.e. GIRK for Kir3 and KATP for Kir6.2.
The first two-pore domain potassium (K2P) channel ever described was discovered only 25 years ago in Saccharomyces cerevisiae, TOK1 (Ketchum et al. 1995). A year later, dORK (K2P0) in Drosophila melanogaster (Goldstein et al. 1996)) and finally TWIK1 (K2P1) in humans (Lesage et al. 1996) were discovered. K2P channels contribute to a K+ leak current in excitable and non-excitable cells (Czirjak and Enyedi 2002). This resting or background conductance is critical in motoneurons (Berg et al. 2004; Talley et al. 2000), dorsal root ganglion neurons (Kang and Kim 2006; Pereira et al. 2014), or cerebellar granule neurons (Plant et al. 2002). Whereas “leakage current” typically refers to a non-selective current following membrane damage, K2P channels support a K+-selective leak that is fairly voltage-independent. At rest, open K2P channels enable K+ efflux due to K+ concentration gradient, making the intracellular more negative, limiting further K+ efflux and suppressing depolarization. Under physiological conditions, neurons display a resting membrane potential (Vm) of −60 to −90 mV, while the equilibrium potential for K+ (EK) is approx. −90 mV, with a K+ concentration of 5 mM outside and 140 mM inside at 37°C. Nevertheless, K+ leakage contributes more to the Vm. K2P channels affect the frequency, duration, and amplitude of action potentials. K2P are tightly regulated by splicing, post-translational modifications (phosphorylation, sumoylation, glycosylation) and numerous chemical (phospholipid composition, GPCR activation, second messengers) and physical agents (extracellular and intracellular pH, mechanical stretch, temperature) (Gada and Plant 2019; Goldstein et al. 2001; Niemeyer et al. 2016). Currently, the K2P family is composed of 15 different subunits (K2P1–15) and encoded by genes numbered KCNK1–18 (no expression has been found for KCNK8, KCNK11, or KCNK14). They have been historically grouped according to structural and functional relatedness in six subfamilies: TREK1-TREK2-TRAAK (K2P2-K2P10-K2P4), TALK1-TALK2 (K2P16-K2P17), TWIK1-TWIK2 (K2P1-K2P6), TASK1-TASK2-TASK3-TASK5 (K2P3-K2P5-K2P9-K2P15), THIK1-THIK2 (K2P12-K2P13), and TRESK (K2P18). Like Kir channels, K2P channels are also commonly referred to via their functional name.
2 Subunits/Assembly/Topology
Potassium channels share many similarities when it comes to their topology, assembly, and subunit composition. However, there are some key differences, which we will explore here. For voltage-gated potassium channels each Kv channel is a tetramer composed of similar or identical pore-forming α subunits, and in some cases also contains auxiliary β subunits which can alter channel localization and/or function (A-González and Castrillo 2011; Abbott et al. 2006). The α subunits are arranged around a central axis that forms a pore (Coetzee et al. 1999). Each α subunit is a polypeptide with 6 transmembrane domains (S1-S6) and five loops connecting the segments (Fig. 2). The N- and C-terminal regions are cytoplasmic. The pore-forming region of the channel is produced by the S5-S6 linker (P-loop) and contains the K+ selectivity filter (Heginbotham et al. 1994). The voltage-sensing domain (VSD) is formed by segments S1-S4 that control pore opening via the S4-S5 intracellular loop that is connected to the pore domain (Bezanilla 2000; Cui 2016; Gandhi and Isacoff 2002; Schmidt and Mackinnon 2008). Within each subfamily both homomeric and heteromeric channels may form with a range of biophysical properties (Abbott et al. 2006; Albrecht et al. 1995), leading to a large diversity of channels.
KCa channels basic topology is similar to that of Kv channels; in fact, both families belong to the 6/7TM group of K+ channels (Gutman et al. 2005; Wei et al. 2005). Cryo-EM structures of the full length KCa1.1 channel have provided extensive information about its structure and gating (Hite et al. 2017; Tao et al. 2017) (PDB: 5TJ6 and 5TJI, respectively). Importantly, small and large conductance subfamilies of KCa channels have two main differences in their structure: KCa1.1 channels have an additional transmembrane domain, S0, and their S4 transmembrane domain is voltage-sensitive (Fig. 2) (Kshatri et al. 2018). Due to the S0, the N-terminus is extracellular, and the large C-terminal domain that comprises around two-thirds of the protein is intracellular (Meera et al. 1997). Like the Kv, the S1-S4 transmembrane segments of the KCa1.1 channel form the VSD (Diaz et al. 1998; Ma et al. 2006) and the S5-S6 segments contain the P-loop with the K+ selectivity filter (Meera et al. 1997). Another major difference between KCa1.1 channels and KCa2.x/KCa3.1 is the cytoplasmic C-terminal domain, which in KCa1.1 channels contains two regulating conductance of K+ (RCK) domains, RCK1 and RCK2 (Yuan et al. 2010). X-ray crystal structures of the isolated C-terminus of KCa1.1 have provided valuable structural information about RCK1 and RCK2 (PDB: 3NAF) (Yuan et al. 2011). Both RCK domains possess a high affinity Ca2+-binding site: a string of negatively-charged aspartate residues located at RCK2, labeled as the Ca2+-bowl (Schreiber and Salkoff 1997), and a site containing the residues D362 and D376 in RCK1 (Yuan et al. 2010). Four of these pore-forming subunits of KCa1.1 (α subunit) assemble to form functional homotetramers (Shen et al. 1994).
KCa2.1-KCa2.3 and KCa3.1 channels share with Kv channels the six TM domain (S1-S6) topology (Kohler et al. 1996), with the S5 and S6 TM pore-forming domains, and the N- and C-terminal domains facing the cytosol (Kshatri et al. 2018). Unlike Kv and KCa1.1 channels, the S4 domain lacks voltage sensitivity, and therefore gating is membrane potential independent (Hirschberg et al. 1999). In the cytosolic C-terminal domain of small conductance KCa channels, a calmodulin (CaM) binding domain (CaMBD) (Adelman 2016; Fanger et al. 1999) is located that indirectly confers Ca2+ sensitivity (Xia et al. 1998). In general, KCa2.1-KCa2.3 and KCa3.1 assemble in homotetramers to form functional channels (Kohler et al. 1996; Sforna et al. 2018), but KCa2.1-KCa2.3 can also arrange in heterotetramers (Strassmaier et al. 2005).
Kir channels share a relatively simple topology, as compared to Kv and KCa channels (Fig. 2). They contain two transmembrane domains, TM1 and TM2, separated by a linking pore-forming P-loop sequence that includes the K+ selectivity filter (Heginbotham et al. 1994). The cytoplasmic N- and C-terminal domains form a characteristic cytoplasmic extended pore structure (Fig. 2) (Nishida et al. 2007). Four subunits associate to form functional homotetramers or heterotetramers. While Kir1.1 and Kir7.1 can only form homotetramers (Kumar and Pattnaik 2014; Leng et al. 2006), the majority of Kir channels assemble with subunits within the same subfamily (Hibino et al. 2010). Kir4.x forms homotetramers (Pessia et al. 2001), while the formation of functional Kir5.1 homotetramers has not been described yet (Hibino et al. 2010). However, Kir5.1 can associate with Kir4.1-Kir4.2 to form functional channels (Kir4.1-Kir5.1 or Kir4.2-Kir5.1) (Pessia et al. 2001).
Like Kir channels, K2P channels also contain a simplified topology, compared to Kv and KCa channels (Fig. 2). K2P channels contain the two pore-forming P loops (P1, P2), where the K+ selectivity filter can be found, and four transmembrane helices (TM1-TM4). The first pore-forming P-loop sequence (P1) is located in between TM1 and TM2, while the second one (P2) is found between TM3 and TM4. The 2P/4TM topology (2P/8TM for TOK1) is unique among other K+ channels (1P/6TM for Kv or 1P/2TM for Kir). However, despite differences in the topology, the overall K2P channel structure does not differ much from Kv, KCa, and Kir channels, due to its pseudo tetrameric architecture. Each protomer (2P) will assemble to form a dimer (2x2P = 4P) to recreate a classic tetrameric K+ channels configuration (4x1P = 4P) (Gada and Plant 2019; Goldstein et al. 2001; Niemeyer et al. 2016). The P1 and P2 loops share high homology with the Kv channel P-loop (Fig. 3). K2P channels also possess an extracellular cap domain, constituted by the external loop located in between TM1 and P1. The two subunits assemble their helical caps to generate two lateral tunnels where the ions move from the exterior to the pore (extracellular ion pathway). This assembly is stabilized in most K2P channels by a disulfide bond (Lesage et al. 1996; Niemeyer et al. 2003). The cap impedes direct ion transport between the pore and the extracellular medium.
3 K+ Selectivity
All four families of K+ channels are highly selective for K+. This is accomplished through a structure referred to as the selectivity filter (SF), which allows for the discrimination between K+ and other cations, in particular Na+ (Hille 1986) (Fig. 3). Kv channels also contain a gate at the bundle crossing on the intracellular side of the membrane, which is responsible for opening in response to a voltage stimulus. Together, these determine when the channel conducts K+ (Liu et al. 2015). KCa1.1 channels are impermeable to Na+ and Li+ (Blatz and Magleby 1984; Tabcharani and Misler 1989), while KCa2.x and KCa3.1 channels are slightly less selective, allowing some Na+ and Li+ permeation (Shin et al. 2005). In some Kir channels, strict K+ selectivity also involves residues outside the SF that contribute to keep its structure (Makary et al. 2006; Yi et al. 2001). Particularly, Glu139 and Arg149 in GIRK1, Glu152 in GIRK2, or Glu145 and Arg155 in GIRK4 are suggested to form a salt bridge behind the selectivity filter that confers rigidity to its structure, and mutations in these amino acids lead to a substantial loss of K+ selectivity (Makary et al. 2006). However, Kir7.1 exhibits an unusual larger inward conductance of Rb+ over K+ (Wischmeyer et al. 2000). K2P channels are also highly selective for K+. However, TWIK1 can alter its selectivity to Na+ under hypokalemia, which can lead to depolarization (Chatelain et al. 2012; Ma et al. 2011). Moreover, TASK and TWIK change ion selectivity in response to extracellular acidification (Ma et al. 2012).
The selectivity filter is comprised of a highly conserved region in the P-loop, containing the T-I/V-G-Y/F-G consensus sequence (Bichet et al. 2003; Doyle et al. 1998; Heginbotham et al. 1994; Varma et al. 2011; Zhou et al. 2001b) (Fig. 3). This signature sequence creates a narrow conduit that can accommodate multiple unhydrated K+ ions (Nishida et al. 2007), which transit between the central cavity of the channel and the extracellular solution. The geometry and polarity of these sites mimic the dipoles of water and thermodynamically favor binding of K+ over Na+ (Åqvist and Luzhkov 2000; Bernèche and Roux 2001; Noskov et al. 2004; Roux 2005; Shrivastava et al. 2002). In this way, water molecules are stripped from K+, which passes through in single file through the filter. Na+ remains bound to water molecules (they have higher dehydration energy) and is energetically unfavorable for passing through the selectivity filter.
Mutagenesis studies on Kv channels first revealed the importance of the selectivity filter (Heginbotham et al. 1994). Some members of the Kir channel family have shown how alterations of the signature sequence lead to loss of K+ selectivity. Particularly, a serine substitution at glycine-156 in Kir3.2 (GIRK2) channels produces a loss of K+ selectivity, allowing Na+ entry and inappropriate cell depolarization (Slesinger et al. 1996; Tong et al. 1996) that leads to death, and is responsible for the weaver mouse phenotype (Patil et al. 1995). Recently, an L171R mutation near the selectivity filter in human GIRK2 was reported for a patient with a severe hyperkinetic disorder that also eliminated K+ selectivity (Horvath et al. 2018).
For K2P channels, the selectivity filter is located below the cap domain and is disposed in a convergent fourfold symmetric configuration to emulate hydration of K+ ions. Despite some differences, K2P channels exhibit similar sequences to the T-I/V-G-Y/F-G consensus sequence (Schewe et al. 2016) (Fig. 3). Interestingly, the specific sequence composition can confer the channel a change in ion selectivity under certain conditions. For example, the presence of a second threonine (Thr118) within the selectivity filter of TWIK1 enables the channel to support Na+ leak currents (Ma et al. 2011).
4 Gating Mechanisms
One of the areas where there is a large divergence in K+ channels is through their different gating mechanisms. The Kv class of channels are voltage-dependent and have evolved to use the power of the electric field that exists across excitable membranes to move charged groups of ions crosswise across the membrane (Ishida et al. 2015; Schmidt and Mackinnon 2008). Voltage-dependent gating of Kv channels involves several molecular processes including: (1) detection of changes in voltage across the membrane by the voltage-sensing domain (VSD). VSD activation results in conformational rearrangement leading to (2) propagation of VSD movements to the ion conduction pore via a helical linker (Khalili-Araghi et al. 2006). Rearrangement of the pore, via VSD-pore coupling, results in (3) pore opening and ion conduction into the cell (Cui 2016). The VSD can adopt a stable conformation in the absence of the rest of the channel (PD) (Chakrapani et al. 2008; Krepkiy et al. 2009). One of the first VSDs defined at the atomic level and considered a native, non-altered structure was part of the mammalian Kv1.2 channel (PDB: 2A79) (Long 2005). This structure showed that the VSD interacts with the pore domain of an adjacent subunit where the voltage sensor is latched around the pore of an adjacent subunit and voltage sensing in one subunit would affect the pore region of another subunit (Long et al. 2007).
A key characteristic of the VSD is the presence of basic amino acids, including positively charged arginine and lysine amino acids in the S4 segment, in a repeating motif of one positive charge separated by two hydrophobic residues. The number of positive charges is variable, with some Shaker related channels having as many as seven (Zhou et al. 2001a). Most models of voltage-dependent gating suggest that as transmembrane voltage changes polarity during depolarization, with the cytoplasmic side becoming positive, the energy exerted on the S4 charges is altered and moves the S4 segment. The S4 segment appears to translate and rotate counterclockwise (Ahern and Horn 2005; Larsson et al. 1996). The C-terminal portion of the S4 segment is accessible to the intracellular solution at rest and as depolarization occurs, the charged residues become less accessible to the intracellular solution and instead become more accessible to the extracellular solution, resulting in the S4 segment moving to an external position (Ahern and Horn 2004, 2005; Baker et al. 1998; Broomand and Elinder 2008; Gandhi and Isacoff 2002; Larsson et al. 1996; Lin et al. 2011). The result is channel activation, leading to opening of the water-filled channel and the flow of K+ down the electrochemical gradient out of the cell. As the membrane potential repolarizes, the VSD returns to the resting state, which in turn closes the channel and terminates K+ permeability.
Kv channels can exhibit various types of inactivation, each involving distinct mechanisms. In some channels, inactivation occurs soon after the channel is activated. This fast inactivation, or N-type inactivation, is mainly due to an intracellular block of the channel by the intracellular N-terminus, often referred to as the inactivation particle (Aldrich 2001). A relatively slower form of inactivation termed C-type occurs after tens or hundreds of milliseconds have elapsed following channel activation (Pau et al. 2017). It appears that the pore structure of this class of channels and the permeating ions play a pivotal role in this process; however, it remains the subject of investigation (Hoshi and Armstrong 2013). Modulation of the inactivation process conveys the ability to control the cellular availability of Kv channel currents. In some cases, inactivation is sensitive to the cellular redox environment (Sahoo et al. 2014). A structural component within the N-terminus has been identified that serves as a sensor for the cytoplasmic redox potential (e.g., exposure to oxidizing agents) and leads to inactivation of the channel (Finol-Urdaneta et al. 2006).
Two different gating mechanisms can be observed in KCa channels: voltage and calcium-dependent gating for KCa1.1 channels, and calcium-dependent for small and intermediate conductance KCa channels (Fakler and Adelman 2008). Large conductance KCa1.1 channels exhibit voltage sensitivity similar to Kv channels; membrane depolarization and intracellular Ca2+ combine allosterically to activate the channel and open the inner pore (Horrigan and Aldrich 2002). Four RCK1-RCK2 intracellular domains of the KCa1.1 tetrameric assembly comprise the gating ring (Hite et al. 2017; Yuan et al. 2011). Upon Ca2+ binding to the Ca2+-sensitive sites in the gating ring, an aspartate string in RCK1 and the Ca2+ bowl in RCK2, the RCK1-RCK2 tandems rearrange to open the gating ring (Yuan et al. 2011). When Ca2+ binding to the intracellular domain of the channel combines with the activation of the VSD by membrane depolarization, the chemical and the electrical energies released additively fuel the conformational change of the PD from the closed to the open state (Hite et al. 2017; Horrigan and Aldrich 2002), in a process that requires the interaction of the gating ring with the VSD (Hite et al. 2017). As the membrane voltage depolarizes, the intracellular Ca2+ concentration ([Ca2+]i) required to activate KCa1.1 decreases (Cui et al. 1997), ranging from 0.5 to 50 mM (Xia et al. 2002). A regulatory Mg2+-binding site, located in RCK1, has also been described for KCa1.1 channels (Shi and Cui 2001), through which Mg2+ contributes to channel activation (Xia et al. 2002; Yang et al. 2008).
In contrast to KCa1.1 channels, gating is voltage-independent in KCa2.x and KCa3.1 channels (Hirschberg et al. 1999). Ca2+ activates KCa2.x and KCa3.1 channels through binding to the highly Ca2+-sensitive protein calmodulin (CaM), which is constitutively associated to α subunits of the channel (Fanger et al. 1999; Sforna et al. 2018; Xia et al. 1998). The binding of Ca2+ to KCa2.x and KCa3.1 channels through CaM accounts for their elevated Ca2+ sensitivity compared to submicromolar sensitivity of KCa1.1 channels (Adelman et al. 2012; Xia et al. 1998). KCa2.x and KCa3.1 channels interact with CaM through a highly conserved CaM binding domain (CaMBD) (Adelman 2016; Fanger et al. 1999) in each α subunit of the channel, and it has been confirmed by cryo-EM (Lee and MacKinnon 2018). Ca2+ binding to the EF-hand domains in the N-lobe of CaM promotes the rearrangement of two CaM-CaMBD dimers into a “dimer of dimers,” that leads to the conformational change of the helices forming the pore required for channel opening (Lee and MacKinnon 2018; Schumacher et al. 2001).
For Kir channels, the inward rectification is their most distinctive feature. In fact, different levels of inward rectification can be described in Kir channels, ranging from strong inward rectifiers, such as Kir2.1-Kir2.4, to medium, e.g. GIRK1-GIRK4, and to weak, such as Kir1.1 and Kir6.1-Kir6.2 channels (Hibino et al. 2010; Walsh 2020). Although Kir channels are not intrinsically voltage-dependent, since they lack the voltage-sensing S4 domain (Hibino et al. 2010), the inward rectification shows an apparent voltage sensitivity. Inward rectification is mediated by intracellular Mg2+ (Lu and MacKinnon 1994; Matsuda et al. 1987) and naturally occurring polyamines (e.g., putrescine2+, spermidine3+, and spermine4+) (Lopatin et al. 1994; Nichols and Lee 2018). At membrane potentials positive to the equilibrium potential of K+ (EK ≈ −95 mV), Mg2+ and polyamines occlude the inner vestibule, only allowing a small outward current. In contrast, at potentials negative to EK, Mg2+ and polyamines flow out of the channel into the cell, allowing a large inward K+ current (Lopatin et al. 1995). The affinity of Mg2+ and the polyamines for binding sites in the pore-forming TM2 helix (Stanfield et al. 1994; Wible et al. 1994) and the cytoplasmic domain of Kir channels (Kubo and Murata 2001; Taglialatela et al. 1995) dictates the strength of the inward rectification (Baronas and Kurata 2014; Clarke et al. 2010). Besides Mg2+ and polyamines, Kir channels K+ conductance is also influenced by extracellular K+ concentrations ([K+]o) (Lopatin and Nichols 1996), being this conductance higher at increasing [K+]o (Hibino et al. 2010). Kir7.1 is an exception and exhibits only a slight dependence on [K+]o due to the presence of a methionine at position 125 in the pore domain, instead of the conserved arginine found in the majority of Kir channels (Doring et al. 1998). The intrinsic gating of Kir channels is controlled by two gating structures: the bundle-crossing region in the TM2 of the transmembrane domain (Sadja et al. 2001; Yi et al. 2001) and the G loop in the cytoplasmic domain (Pegan et al. 2005). The first Kir channel structures to be resolved, involving bacterial Kir channels, such as KscA (Doyle et al. 1998) (PDB: 1BL8) and KirBac1.1 (Kuo et al. 2003) (PDB: 1P7B), pointed at TM1 and TM2 as key players in the gating of Kir channels. The gating of some Kir channels depends on other regulators, apart from Mg2+, polyamines, and [K+]o, such as pH, Na+, ATP, and/or G proteins (Hibino et al. 2010). For instance, changes in the intracellular pH alter the gating of Kir1.1 (Schulte and Fakler 2000), Kir4.1-Kir4.2 (Pessia et al. 2001), and Kir5.1 (Tucker et al. 2000), which are closed upon intracellular acidification, while Kir7.1 shows maximal response at pH 7.0 (Yuan et al. 2003). In fact, homomeric Kir4.1 and Kir4.1/Kir5.1 channels exhibit different pH sensitivities (Casamassima et al. 2003). In the case of Kir2.1-Kir2.4 channels, intracellular alkalization activates Kir2.4 (Hughes et al. 2000), while either extracellular or intracellular alkalization enhances Kir2.3 activity (Zhu et al. 1999). Kir6.1-Kir6.2 channels, also called KATP, are regulated by intracellular ATP, which leads to the inactivation of the channel (Terzic et al. 1995), while intracellular nucleoside diphosphates, such as ADP, activate the channel through the interaction with SUR, the auxiliary subunits of Kir6.1-Kir6.2 channels (Hibino et al. 2010; Matsuoka et al. 2000). G-protein gated Kir channels (GIRK) are opened by an interaction of the Gβγ subunit with the βL-βM sheets in the cytoplasmic C-domain of GIRK (PDB: 4KFM) (Finley et al. 2004; He et al. 1999; Ivanina et al. 2003; Whorton and MacKinnon 2013), producing a conformational change that opens the channel pore in a PIP2-dependent process (Huang et al. 1998; Whorton and MacKinnon 2013). Moreover, the gating of GIRK channels containing GIRK2 or GIRK4 subunits is also influenced by intracellular Na+ (Ho and Murrell-Lagnado 1999), which promotes the binding of PIP2 to the channel and activation (Rosenhouse-Dantsker et al. 2008). The structural binding site for Na+ has been identified in a GIRK2 X-ray structure (PDB: 3SYA) (Whorton and MacKinnon 2011). In this way, the intracellular Na+ increase after cell depolarization enhances the activity of GIRK channels, bringing the cell back to the resting state.
Like Kv, KCa, and Kir channels, K2P possesses a gating hinge (Brohawn et al. 2012; Miller and Long 2012; Niemeyer et al. 2016). TM1 and TM3 are located on the outer pore, while the inner helices, TM2 and TM4, play a crucial role in channel activation. The TM4 helix motion, up and down (closer and farther TM2 helix), is a pivotal determinant of the open-close configuration. The interfacial C helix is adjacent to TM4 and movement is transferred to the TM2-TM4 hinge to support pore widening and ion conduction (Brohawn et al. 2012; Miller and Long 2012; Niemeyer et al. 2016). K2P channels are sensitive not only to cytosolic factors, but also to membrane components (and/or alterations). K2P channels also possess intramembrane openings that confer connections between lipid membrane and ion pore. These openings, termed fenestrations, have been named for analogous side portals present in prokaryotic voltage-dependent Na+ channels (Payandeh et al. 2011). They are located in between the TM2 of one protomer and the TM4 of the other one. The two transmembrane cavities can accommodate acyl chains and influence the channel conductivity (Brohawn et al. 2014).
Although many factors can modulate K2P gating, the extracellular pH (pHo) is probably the best characterized. Many K2P channels have a histidine located at the entrance of the selectivity filter (TM1-P1) that is protonated upon pHo decrease. In TASK1 (His98), TASK3 (His98), TWIK1 (His122), and TREK1 (His126), histidine protonation prevents the ion passage. Thus, channel closure is similar to C-type inactivation in Kv channels (Chatelain et al. 2012; Cohen et al. 2008; Kim et al. 2000; Lopes et al. 2001; Rajan et al. 2000). Uniquely, extracellular acidification induces channel activation in TREK2 (His151) and involves a region of the P2-TM4 extracellular loop (Sandoz et al. 2009). Interestingly, TWIK1 switches ion selectivity upon a decrease in pHo (Ma et al. 2012). Histidine is not the only basic residue in K2P channels that can operate as H+ sensor. TASK2 lacks the histidine sensor but has an arginine (Arg224) at the second pore domain that confers selectivity filter pHo-sensing as well. TASK2 is inhibited by acidic pHo, and surprisingly activated when pHo increases. In this case, protonation/deprotonation of the side chain of the residue alters the electrostatic stability on the selectivity filter (Niemeyer et al. 2007; Zuniga et al. 2011). Additionally, some K2P channels respond to intracellular pH (pHi) alterations. Thereby, K2P channels such as TREK1 or TASK2 switch from low to high activity upon intracellular acidification. The mechanism does not involve any residue in the selectivity filter, but an acidic amino acid in the interfacial C helix (i.e., Glu306 in TREK1), working as an activation gate (Bagriantsev et al. 2011).
In addition to pH, the intracellular C-terminus also supports different gating mechanisms. TREK1 possesses a group of positively charged residues in the C helix that confers the channel the capacity to respond to phospholipids (Chemin et al. 2007). TREK1 also contains a phosphorylation site (Ser348) in the C-terminus that alters channel gating properties, switching the channel from a voltage-independent into a voltage-dependent phenotype (Bockenhauer et al. 2001). The interfacial C helix is also modulated by GPCR activation. TASK2 is closed by direct G protein βγ subunits binding at the Lysine 245 (Anazco et al. 2013; Niemeyer et al. 2016). TASK1 and TASK3 are also closed by G protein α subunit induced diacylglycerol (DAG) generation that is believed to bind the C-terminal domain (Wilke et al. 2014). Physical stimuli such as pressure and temperature also influence K2P gating. Little is known about the specific mechanism but surely involves the intracellular C-terminus (Bagriantsev et al. 2011). For instance, partial deletion of the interfacial C helix in TREK1 lowers heat-induced activation (Maingret et al. 2000). Besides the C-terminus domain that operates as cytosolic gate, K2P channels show an inner gate that modulates the pore conductivity by membrane composition. The current hypothesis sustains that intramembrane fenestration determine TM4 position over TM2, working as a gating hinge and affecting the selectivity filter. Thus, two possible conformations exist: 1) when the lipid acyl chains penetrate into the fenestration up to the cavity located below the selectivity filter, the TM4 helix is in the down conformation and the ion transit is hindered, and 2) in contrast, when the lipid fenestration is empty, TM4 moves up towards TM2 (up conformation), closing the fenestration and releasing the selectivity filter, which can accommodate an extra ion and facilitate ion conduction (Brohawn et al. 2014).
Recent structural determinations support some of these gating mechanisms. TREK2 structure resolved with the inhibitor fluoxetine exhibits a down conformation (PDB: 4XDJ) (Dong et al. 2015). On the other hand, TRAAK crystallization in the presence of the activator trichloroethanol shows the up conformation (PDB: 3UM7) (Brohawn et al. 2014). Moreover, artificially trapping TRAAK into the up state, by a disulfide bridge between TM4 and TM2, induces the channel to a reversible low activity profile. The least understood gating mechanism is the effect of membrane voltage. Although K2P channels lack a specific voltage-sensing domain (i.e., S4 in Kv) and the first leak K+ channels were initially described as a voltage-independent outward rectifier K+ channels (Goldstein et al. 2001), some K2P (except for the unphosphorylated TWIK1) can unequivocally alter their activity in response to membrane potential changes. It has been recently proposed that a one-way “check valve” mechanism, in which the selectivity filter acts as a voltage-gate, takes place. Depolarization induces filter opening and outward K+ flow, whereas at membrane potentials below EK the non-return valve promotes filter inactivation. The second threonine (i.e., Thr157 in TREK1 or Thr103 in TRAAK) in the selectivity filter of P1 plays a major role in this mechanism. Thus, mutagenesis experiments in TREK1 and TRAAK turn them into a leak mode (Schewe et al. 2016). Interestingly, TREK1 voltage-gated mode is abolished upon pHi, pressure and PIP2 activation (Chemin et al. 2005).
5 Role of Lipids/PIP2
It has been widely recognized that the lipid bilayer can modulate the function of K+ channels (Forte et al. 1981; Van Dalen and De Kruijff 2004). One such role is for inactivation of Kv channels, where interaction with the membrane causes prolonged channel closing (Schmidt et al. 2009; Schmidt and Mackinnon 2008). Using Kv1.2 as an example, the VSDs are embedded in the membrane, with S4 being mostly shielded away from lipids (Long 2005). The top gating charges found in S4 have been modeled to interact with lipid headgroups, making stable electrostatic interactions with their negatively-charged phosphates (Cuello 2004; Lee and Mackinnon 2004; Long et al. 2007). The mechanical properties of the membrane are dictated by lipid composition, and interaction with the headgroups can facilitate sensor movement and subsequently pore opening.
A version of the Kv channel, lacking a sensor region (PDB: 1K4C), exhibits four immobilized lipids filling and surrounding a crevice between subunits on the extracellular surface of the channel, suggesting affinity for lipids at this region (Santos et al. 2012). Inclusion of lipids with headgroups that coat the extracellular membrane-solution interface with hydroxyl groups (e.g., glycerol and phosphoinositol) drastically increases the probability of finding the channel open (Syeda et al. 2014), suggesting that the pore-forming region of the Kv channels may be transformed into an open conductor of K+ through interaction with lipid modulators that target either the bundle gate, via direct interaction, or the filter gate, by destabilization of water structure. So, not only are lipids critical for proper protein folding (Valiyaveetil et al. 2002), they also allow for modulation of channel properties. An example of this would be the Kv7 channel, where channel opening requires the membrane lipid PIP2, which serves as a cofactor that mediates coupling of VSD with the pore gate (Zaydman and Cui 2014).
For KCa channels, several membrane and cholesterol-related lipids have been shown to modulate the activity of some of these channels. For instance, the membrane lipid phosphatidylinositol-4,5-bisphosphate (PIP2) influences the activity of small and large conductance KCa channels. KCa1.1 channels can be either activated or inhibited by PIP2, depending on the β auxiliary subunits to which they are associated (Tian et al. 2015). Particularly, PIP2 has an inhibitory effect on KCa1.1 in the absence of auxiliary subunits and when they are in complex with γ1 subunits, while PIP2 activates the channel when it is complexed with β1 or β4 subunits (Tian et al. 2015). Small conductance KCa channels are also modulated by PIP2 (Zhang et al. 2014). This phospholipid acts as a cofactor for KCa2.x channels activation by CaM upon Ca2+ binding, whilst PIP2 removal leads to channel inhibition (Zhang et al. 2014). Moreover, the regulation of KCa2.x by PIP2 is dependent on CaM phosphorylation by casein Kinase 2 (CK2), which phosphorylates the amino acid T80 in CaM weakening the affinity of PIP2 for the CaM-KCa2.x complex (Zhang et al. 2014).
Cholesterol is another membrane lipid that modulates KCa1.1 activity (Dopico and Bukiya 2017). The cytosolic C-terminal domain of KCa1.1 channels presents a cholesterol recognition amino acid consensus motif (CRAC4) that confers cholesterol sensitivity to the channel (Singh et al. 2012). Cholesterol has shown to inhibit KCa1.1 channels in heterologous expression systems (Wu et al. 2013), although the in vivo effects of cholesterol enrichment or depletion on KCa1.1 channels activity are in some cases contradictory, depending on the tissue where the channel is expressed (Dopico and Bukiya 2017). KCa1.1 channel activity is modulated as well by certain steroid hormones such as 17β-estradiol or dehydroepiandrosterone (DHEA). When co-expressed with β1 auxiliary subunits, KCa1.1 channels are activated by 17β-estradiol, which exerts no effect on KCa1.1 α subunits alone (Valverde et al. 1999), nor when they are associated with β2 subunits (King et al. 2006). However, the adrenal androgen DHEA is able to activate β2-associated KCa1.1 channels, an effect also exerted by corticosterone (King et al. 2006). The bile acid lithocholate and the non-steroid leukotriene LTB4 are also potentiators of KCa1.1 channels activity in a β1-dependent manner (Bukiya et al. 2007, 2014). Lastly, the omega-3 lipid docosahexaenoic acid activates β1 and β4-associated KCa1.1 channels, exhibiting no effect when the pore-forming α subunits are in complex with β2 or γ1 subunits (Hoshi et al. 2013). The auxiliary subunit-dependent activation of KCa1.1 channels exerted by some of these lipids could be contributing to vascular smooth muscle relaxation and consequently to vasodilation (Latorre et al. 2017).
The activation of all Kir channels is also dependent on PIP2 (Hibino et al. 2010; Rohacs et al. 2003). The structural mechanism of PIP2 binding has been elucidated in two X-ray structures for Kir2.1 and GIRK2 (PDB: 3SPI and 3SYA, respectively) (Hansen et al. 2011; Whorton and MacKinnon 2011). The presence of this membrane phospholipid in the inner surface of the plasma membrane is essential for Kir activation (Huang et al. 1998; Li et al. 1999), as well as for the activation mediated by the different endogenous gating regulators of Kir channels (Du et al. 2004), like Kir6.x activation by ATP (Baukrowitz et al. 1998) and GIRK activation by Na+ and Gβγ (Huang et al. 1998; Rosenhouse-Dantsker et al. 2008). Cholesterol is another membrane lipid that modulates the activity of some Kir channels, such as Kir2.x, that become inactive at increasing concentrations of cholesterol (Romanenko et al. 2004), and GIRK channels, which in contrast are activated by cholesterol in a PIP2-dependent and G-protein-independent manner (Glaaser and Slesinger 2017). Other lipids are also involved in Kir activity modulation. For instance, arachidonic acid has shown to increase the current flow through Kir2.3 containing channels (Liu et al. 2001), and the intracellular increase of long-chain CoA esters has an opposite effect on Kir2.1 and Kir6.x channels, inhibiting the former and activating the latter (Shumilina et al. 2006).
K2P channels are also influenced by surrounding lipids, most likely through the two lateral portals or fenestrations. Many K2P are activated by PIP2 (i.e., TASK1-TASK3, TREK1, and TRAAK) leading to a leak K+ conductance mode. Stimulation of Gq/G11 coupled receptors such as muscarinic M1 induces PIP2 hydrolysis and a subsequent inhibition of TASK1-TASK3, TREK1, and TREK2 (Lopes et al. 2005). However, the relationship between phospholipids and K2P channels can be quite complex in some cases. For example, PIP2 exerts a dual regulation in TREK1. In transiently transfected cells, intracellular PIP2 stimulates TREK1 currents in half of the patches and inhibits currents in the other half. Interestingly, pressure, intracellular acidification, and arachidonic acid induced activation are all blocked by the presence of PIP2. The removal of the C-terminal domain abolished PIP2-inhibitory capacity, suggesting the implication of this region on the PIP2-induced gating regulation (Chemin et al. 2007).
6 Trafficking and Accessory Subunits
Kv channels exhibit subfamily-specific patterns of localization within cells (Vacher et al. 2008). For example, in neurons Kv1 channels are expressed at the axon initial segment (AIS). The AIS plays an important role in generating axonal action potentials. Kv1 channels regulate action potential initiation and propagation (Kole and Stuart 2012). Within this channel, specific amino acid sequence motifs act as trafficking determinants (TDs) and direct the initiation, continuation of expression, and localization of these channels to the AIS. TDs are located within the C-terminal domain and act on different interacting proteins (Magidovich et al. 2006). The C-terminal domains are highly conserved in mammalian channels and include a specific motif within the extracellular loop between TM segments S1 and S2 (McKeown et al. 2008) and an acidic motif in the C-terminus of Kv1 α subunits (Manganas et al. 2001). Some Kv subfamily members contain TDs with lower or higher affinity for interacting proteins. The degree of affinity that different subfamily members have for interacting protein leads to trafficking characteristics that are sensitive to co-assembly (Manganas and Trimmer 2000), where localization depends on the TD-interacting protein coupling. TDs also play a role in trafficking from the endoplasmic reticulum (ER). The composition and stoichiometric assembly of Kv1 heterotetrameric channels produces interaction with different proteins and controls ER export of the channel to different loci (Vacher et al. 2007). For example, Kv1.1 contains an ER retention signal in its extracellular pore domain that inhibits export from the ER (Manganas and Trimmer 2000; Manganas et al. 2001; Zhu et al. 2001). The retention signal overlaps with the binding site for the neurotoxin α dendrotoxin (DTX), suggesting that Kv1.1 retention is due to a DTX-like prototoxin. Phosphorylation also regulates trafficking of Kv1.2, with phosphorylation of specific C-terminal tyrosine residues triggering endocytosis of the channels (Nesti et al. 2004). In addition, phosphorylation at a different C-terminal tyrosine residue regulates Kv1.2 clustering (Gu and Gu 2011; Smith et al. 2012) and serine phosphorylation sites regulate biogenic trafficking (Yang et al. 2007).
Initial biochemical studies on native Kv1 channels indicated the presence of stoichiometric amounts of copurifying protein components that were initially proposed to be β subunits (Parcej and Dolly 1989). In fact, the majority of Kv1 channels in mammalian brain are associated with Kvβ subunits (Coleman et al. 1999; Rhodes et al. 1995, 1996, 1997). There are three genes that encode Kvβ subunits (Kvβ1-Kvβ3), with various alternative splicing leading to a larger number of functionally distinct isoforms (Pongs et al. 1999). Certain Kvβ subunits contain a domain in the N-terminus region that confers the rapid “N-type” inactivation to Kv channels (Rettig et al. 1994). The N-terminus region acts like the inactivation particle found in some Kv channels that works to occlude the pore of the activated Kv1 channels.
For KCa channels, the stable association of the pore-forming α subunits with auxiliary subunits confers versatility in their different physiological roles (Berkefeld et al. 2010). The activity of KCa1.1 channel is regulated by several β and γ subunits, which are expressed in different tissues and modify the biophysical and pharmacological properties of the channel (Latorre et al. 2017; Li and Yan 2016). Four different β subunits, β1-β4, have been identified, all of them composed of two transmembrane domains linked by an extracellular loop and with intracellular C- and N-termini (Latorre et al. 2017). The stoichiometry of the association between α and β subunits is generally considered to be 1:1 (Latorre et al. 2017), as revealed by cryo-EM studies (PDB: 6 V22) (Tao and MacKinnon 2019). Interestingly, functional channels can operate with less than four β subunits, exhibiting a proportional modification of the channel properties as the number of β subunits increases (Wang et al. 2002). β1 subunits are mainly expressed in the vascular smooth muscle (Knaus et al. 1994a; Latorre et al. 2017) and enhance the apparent voltage and Ca2+-sensitivity of the channel (McManus et al. 1995) and slow down activation and deactivation kinetics (Dworetzky et al. 1996). In addition, β subunits provide KCa1.1 channel with distinct pharmacological properties, depending on the β subunit to which they are associated (Latorre et al. 2017; Li and Yan 2016). Similarly to β1, β2 subunits increase the apparent Ca2+-sensitivity in the KCa1.1 channel (Brenner et al. 2000a) and decrease the gating kinetics rate (Brenner et al. 2000a). Moreover, β2 subunits are responsible for KCa1.1 channel inactivation (Wallner et al. 1999; Xia et al. 2003), in a process where the N-terminal domain of β2 behaves like a peptide ball that occludes the KCa1.1 channel (Bentrop et al. 2001; Wallner et al. 1999), resembling the ball-and-chain inactivation of Kv channels. In the case of β3 subunits, four different isoforms have been identified (β3a-d) (Uebele et al. 2000), which do not affect KCa1.1 channel Ca2+-sensitivity (Latorre et al. 2017). Alternately, β3a, β3b, and β3c isoforms exert a partial inactivation of the channel (Uebele et al. 2000), while β3b is also responsible for conferring an outward rectification via the extracellular loop (Uebele et al. 2000; Zeng et al. 2003). On the other hand, β4 subunits are mainly expressed in the brain (Weiger et al. 2000) and slow down the activation and deactivation kinetics of KCa1.1 channels (Behrens et al. 2000; Weiger et al. 2000). β4 subunits display a dual effect on Ca2+-sensitivity of KCa1.1 channels: it is reduced in the presence of β4 at low [Ca2+]i, while β4 enhances channel Ca2+-sensitivity at high [Ca2+]i conditions (Brenner et al. 2000a; Wang et al. 2006).
Four γ subunits have been described (γ1-γ4) (Latorre et al. 2017; Li and Yan 2016), each with a single transmembrane domain and large extracellular leucine-rich repeat N-terminal domain (Yan and Aldrich 2012). Although the stoichiometry of γ association with KCa1.1 subunits has not been yet fully elucidated (Latorre et al. 2017), experiments investigating different ratios indicate a single γ subunit can modulate the activity of the α-homotetramer (Gonzalez-Perez et al. 2014). γ1 is the first subunit identified (Yan and Aldrich 2010) and produces a negative shift in the voltage dependence of the activation of the channel (∿140 mV shift) (Yan and Aldrich 2010), leading to the accelerated activation and slower deactivation kinetics, with no effect on Ca2+-sensitivity (Yan and Aldrich 2010). The γ2, γ3, and γ4 subunits also shift the voltage dependence of activation to more negative potentials, although less intensively than γ1 (∿101 mV shift for γ2, ∿51 mV for γ3, and ∿19 mV for γ4) (Yan and Aldrich 2012). Lastly, it has been recently shown that both β2 and γ1 subunits can simultaneously assemble with KCa1.1 homotetramers, endowing the channel with unique gating properties, being active at resting potentials (Gonzalez-Perez et al. 2015).
Apart from the co-assembly with β and/or γ subunits, KCa1.1 channels co-localize in the cell membrane with CaV channels forming multiprotein complexes (Berkefeld et al. 2006, 2010; Grunnet and Kaufmann 2004). Given the Ca2+-sensitivity of these channels, in the micromolar range (Berkefeld et al. 2006), they localize close to Ca2+ sources in the membrane to achieve these Ca2+ concentrations (Augustine et al. 2003; Berkefeld et al. 2006).
For KCa2.x and KCa3.1 channels, CaM is considered the β subunit of these channels (Berkefeld et al. 2010). CaM is constitutively bound to the pore-forming subunits of the channel with a 1:1 stoichiometry (Fanger et al. 1999) and has been visualized with cryo-EM (PDB: 6CNM) (Lee and MacKinnon 2018). CaM is responsible for KCa elevated Ca2+-sensitivity (Xia et al. 1998) and has also been implicated in channel assembly and membrane trafficking (Joiner et al. 2001). Apart from CaM, an additional pair of proteins assembles with the KCa2.x-CaM complexes in the membrane to modulate channel activity: CK2 and protein phosphatase 2A (PP2A) (Adelman et al. 2012; Berkefeld et al. 2010). CK2 and PP2A are constitutively bound to KCa2.x channels, co-assembling with both the CaMBD and the KCa2.x intracellular N-terminal domain, thus forming together with CaM a multiprotein complex (Allen et al. 2007; Bildl et al. 2004). Instead of phosphorylating the KCa2.x subunits, CK2 phosphorylates the amino acid T80 of CaM when the channel is closed, decreasing Ca2+-sensitivity of the channel (Allen et al. 2007). On the other hand, PP2A dephosphorylates CaM in the open state of the channel, allowing it to recover its Ca2+-sensitivity (Allen et al. 2007). In terms of kinase modulation, KCa3.1 activity is influenced by 5’AMP-activated protein kinase (AMPK), which interacts through its γ1 subunit with a leucine zipper domain located in the C-terminus of the channel (Klein et al. 2009).
Kir channels typically associate as homo or heterotetramers without accessory subunits. However, Kir6.x channels function as octamers, composed of four pore-forming Kir6.x subunits, and four auxiliary subunits of the sulfonylurea receptor (SUR1, SUR2A, or SUR2A) (Clement et al. 1997; Shyng and Nichols 1997). The combinations of Kir6.x and SUR auxiliary subunits found in different tissues account for the distinct functional and pharmacological properties of the native channels (Aguilar-Bryan et al. 1998). The intracellular trafficking of some Kir channels is also subjected to protein regulation. Particularly, GIRK channel subunits present trafficking motifs that result in different trafficking patterns of the homo or heterotetramers (Ma et al. 2002). For instance, GIRK2a (a splicing variant of GIRK2) and GRIK4 present an ER export motif in the N-terminal region and a surface-promoting motif in the C-terminal domain that guide the endosomal exportation of GIRK channels containing these subunits to the cell surface (Ma et al. 2002). In contrast, the lysosomal targeting signal present in GIRK3 downregulates the membrane expression of GIRK3-containing channels (Ma et al. 2002). Sorting nexin 27 (SNX27) also regulates the trafficking of GIRK channels, through the interaction of its PDZ domain with the C-terminal domain of GIRK2c and GIRK3, promoting channel trafficking (Lunn et al. 2007; Munoz and Slesinger 2014). Other PDZ-containing proteins play a role in regulating the localization of some Kir receptors in polarized cells, as is the case of Kir1.1 (Yoo et al. 2004), Kir2.3 (Olsen et al. 2002), and Kir4.1 (Tanemoto et al. 2005).
Few associated proteins have been identified for K2P. The first one is AKAP150, which interacts with TREK channels, both TREK1 and 2. Interestingly, AKAP150 is an A-kinase-anchoring protein, key in the native TREK1 environment that can transform small outward TREK1 currents into big leak K+ conductance no longer responsive to pressure, intracellular acidification and arachidonic acid induced (Sandoz et al. 2006). New advances in proteomics will surely bring up new K2P accessory proteins that might be key for its regulation at the activity and trafficking levels. Regulation of K+ channels by auxiliary subunits is described in more detail in chapter “Control of Biophysical and Pharmacological Properties of K+ Channels by Auxiliary Subunits”.
7 Pharmacology: Blockers and Modulators
The structural and functional diversity among K+ channels accounts for the wide variety of toxins and small molecules that modulate the activity of these channels. Various toxins exploit different Kv channel characteristics to exert their actions on the channel. One common class of toxins work by occluding the narrow pore of the channel from its extracellular side preventing ion flow and are referred to as “pore blockers.” Many of these toxins are composed of a positive lysine and a hydrophobic tyrosine/phenylalanine in a dyad motif (Eriksson and Roux 2002; Gao and Garcia 2003; Miller 1995). With this arrangement the lysine residue occludes the Kv channel selectivity filter and prevents K+ ions from entering the channel, at the same time the hydrophobic portion of the dyad aids docking and toxin binding to the channel (Dauplais et al. 1997; Gilquin et al. 2002; Savarin et al. 1998; Srinivasan et al. 2002). Examples of this class of toxins include κM-RIIIK and ConK-S1 from cone snails (Al-Sabi et al. 2004; Jouirou et al. 2004) and ShK from a sea anemone (Finol-Urdaneta et al. 2020). Another distinct mechanism is exhibited by “gating modifiers,” which bind to the extracellular exposed linker between the TM segments S3 and S4 within the VSD. These toxins inhibit channel function, increasing the energy required to open the channel by shifting the voltage dependence to more depolarized potentials raising the activation threshold. An example of this class is the HaTx toxin from spiders (Tudor et al. 1996). δ-dendrotoxin (DTX), isolated from the green mamba snake venom, is another well-known blocker of Kv channels (Harvey and Anderson 1985; Harvey and Robertson 2004). Various toxins, in particular conotoxins produced by marine cone snails, have been employed as molecular tools for the study of Kv channels in mammalian targets (Teichert et al. 2015). You can read more on K+ channel toxins in chapter “Peptide Toxins Targeting Kv Channels”.
In addition to toxins, work is currently being conducted to identify small molecule modulators of Kv channels which could prove useful for treating various brain disorders. For example, Kv channel activators could be used to dampen hyperexcitability for treating epilepsy or attention deficit disorder (Wulff et al. 2009). Kv channel inhibitors, on the other hand, could be used to increase excitability in disorders involving reduced neuronal activity, such as multiple sclerosis (MS). For a detailed review of the potential therapeutic utility of Kv modulators, see (Wulff et al. 2009). One example is 4-aminopyridine (4-AP) which is a non-selective Kv channel inhibitor (Wu et al. 2009) which has undergone phase III clinical trials for the treatment of MS (Goodman et al. 2009; Korenke et al. 2008). Another example is dofetilide, a class III antiarrhythmic and inhibitor of Kv11.1, that is efficacious in reverting and preventing atrial fibrillation of the heart (Kamath and Mittal 2008).
For KCa channels, there are different modulators for large, intermediate, and small conductance channels (Kshatri et al. 2018). For example, KCa1.1 channels are blocked by tetraethylammonium (TEA) (Blatz and Magleby 1984; Villarroel et al. 1988), like many Kv channels (Bretschneider et al. 1999), whereas KCa2.x and KCa3.1 are not affected by this quaternary amine. KCa subtypes also exhibit different sensitivities to toxins (Kshatri et al. 2018). KCa1.1 channels are classically inhibited by the scorpion venom peptide iberiotoxin (IbTX) (Galvez et al. 1990) and charybdotoxin (ChTX) (Miller et al. 1985). The selectivity of ChTX and IbTX for KCa1.1 channels depends on the type of β subunit associated with the α pore-forming subunit, demonstrating how auxiliary subunits can modify the pharmacological properties of the channel (Latorre et al. 2017). For example, association of KCa1.1 channels in complex with β2/3 or β4 subunits decreases the affinity for ChTX (Meera et al. 2000; Xia et al. 1999), while channels associated with β1 are highly sensitive to ChTX (Hanner et al. 1997). In the case of IbTX, β4-associated KCa1.1 channels are resistant to the blockade by this toxin (Meera et al. 2000). Slotoxin (Garcia-Valdes et al. 2001) and martentoxin (Shi et al. 2008), two scorpion venom toxins closely related to ChTX and IbTX, are potent KCa1.1 blockers. Their affinity for the channel is also dependent on the β subunit composition, with slotoxin weakly blocking KCa1.1 channels assembled with β4 subunits (Garcia-Valdes et al. 2001), while martentoxin exhibits an opposite behavior and selectively blocks α + β4 KCa1.1 (Shi et al. 2008). Other natural toxins that inhibit KCa1.1 channels are the scorpion venom toxin BmP09 (Yao et al. 2005), and the fungal alkaloids paxilline, panitrem, and lolitrem B, which have shown to block the channel at low nanomolar concentrations (Imlach et al. 2009; Knaus et al. 1994b). KCa2.x channels are characterized by their sensitivity to inhibition with the bee venom toxin apamin (to which KCa1.1 are insensitive) (Grunnet et al. 2001; Weatherall et al. 2010). KCa2.x channels are also inhibited by the scorpion venom toxin tamapin (Pedarzani et al. 2002). Lastly, like KCa1.1 channels, KCa3.1 are blocked by ChTX (Sforna et al. 2018; Wei et al. 2005) and by another scorpion venom peptide toxin, maurotoxin (Castle et al. 2003), the latter having a high affinity and selectivity for this subfamily of KCa channels (Castle et al. 2003).
For small molecule modulators of KCa channels, several activators and inhibitors have been described for the different subfamilies. For example, KCa1.1 channels are activated by the synthetic compounds NS1608 (Strobaek et al. 1996) and BMS-204352 (Gribkoff et al. 2001), which show promise in in vivo models for the treating fragile X syndrome (Hebert et al. 2014). For KCa2.x channels, the inhibitors UCL1684 (Strobaek et al. 2000) and NS8593 (Strobaek et al. 2006) have been described. Regarding KCa2.x activators, CyPPA (Hougaard et al. 2007), NS13001 (selective for KCa2.2/KCa2.3) (Kasumu et al. 2012), and NS309 (Strobaek et al. 2004) are of notice, the latter acting by increasing the Ca2+-sensitivity of the channel. Moreover, the KCa2.x activator EBIO (Devor et al. 1996) has shown in vivo efficacy as an anticonvulsant (Anderson et al. 2006). Chlorzoxazone is a KCa2.2 activator (Cao et al. 2001) and muscle relaxant that has been approved for the treatment of severe spasticity (Losin and McKean 1966). For KCa3.1 channels, the antifungal drug clotrimazole is a classical small molecule blocker (Wulff et al. 2000), and has been used as scaffold for the development of KCa3.1 inhibitors such as TRAM-34, which exhibits high selectivity for KCa3.1 (Wulff et al. 2000). On the other hand, some KCa2.x activators also act on KCa3.1 channels to enhance their activity, such as for the benzimidazolones EBIO (Devor et al. 1996), DCEBIO (Singh et al. 2001), NS309 (Strobaek et al. 2004), and SKA-31 (Sankaranarayanan et al. 2009). In short, the strategies that pursue the activation of KCa1.1 and KCa2.x channels, or the inhibition of KCa3.1 channels, are the most important when it comes to the treatment of diseases involving KCa channels (Kshatri et al. 2018).
While the biophysical features of Kir channels have been thoroughly studied, their pharmacological modulation remains largely unexplored. Initially, inorganic cations like Ba2+ and Cs+ were found to block the majority of Kir channels (Hagiwara et al. 1976, 1978), in a voltage- and [K+]o-dependent manner (Quayle et al. 1993). Nevertheless, Kir7.1 shows a much lower sensitivity to the blockade by these cations (Krapivinsky et al. 1998). Interestingly, the Kv channel blockers tetraethylammonium (TEA) and 4-aminopyridine (4AP) have little effect on Kir channels (Hagiwara et al. 1976; Oonuma et al. 2002). Several naturally occurring toxins have been described as blockers of some Kir channels (Doupnik 2017). The bee venom peptide toxin tertiapin is a Kir1.1 and GIRK channel blocker (Jin and Lu 1998; Kanjhan et al. 2005), as well as its synthetic oxidation-resistant derivative tertiapin-Q (Jin and Lu 1999). Tertiapins are not effective blockers of Kir2.1 channels (Jin and Lu 1998). The scorpion venom peptide toxin Lq2, an isoform of charybdotoxin (ChTX), is also a Kir1.1 blocker, and again has no inhibitory effect on Kir2.1 (Lu and MacKinnon 1997). δ-dendrotoxin (DTX), isolated from the green mamba snake venom, is a well-known blocker of Kv channels (Harvey and Anderson 1985; Harvey and Robertson 2004) that is also a potent Kir1.1 inhibitor (Imredy et al. 1998).
In addition to toxins, small chemical modulators have been isolated that activate some Kir channels. GIRK channels are activated by small molecules such as the ureas ML297 and GiGA1, which have shown promising anticonvulsant (Kaufmann et al. 2013; Zhao et al. 2020) and anxiolytic effects (Wydeven et al. 2014). Ethanol, as well as other short-chain alcohols, also activates GIRK channels (Kobayashi et al. 1999), implicating these channels in alcohol motivational and addictive effects (Rifkin et al. 2017). Activators and inhibitors of Kir6.x, through the interaction with their SUR auxiliary subunits, have therapeutic applications in human (Hibino et al. 2010). For example, sulfonylureas, such as tolbutamide (Ashfield et al. 1999), glibenclamide (Schmid-Antomarchi et al. 1987), or glimepiride, block the Kir6.2/SUR1 channel, stabilizing a conformation of SUR1 that prevents the pore opening (Doyle and Egan 2003). The recent structural determination of the Kir6.2/SUR1 complex by cryo-EM (Lee et al. 2017; Martin et al. 2017) has helped in the identification of the sulfonylurea glibenclamide binding site (PDB: 5TWV) (Martin et al. 2017). These drugs have an important clinical use in the treatment of diabetes mellitus II, since the blockade of Kir6.2/SUR1 expressed in pancreatic β cells promotes insulin secretion (Ashcroft 2005). Potassium channel openers (KCO), such as nicorandil (Horinaka 2011) and pinacidil (Muiesan et al. 1985), activate Kir6.x channels upon SUR binding and are used in the treatment of myocardial infarction, ischemia-reperfusion injury, and hypertension (Grover and Garlid 2000; Mannhold 2004).
For K2P channels, many different halogenated anesthetics, such as isoflurane or sevoflurane, stimulate the channels (i.e., TREK1, TASK1-TASK3, TRAAK, and TRESK). These volatile anesthetics increase K2P channel open probability and K+ conductance, resulting in membrane hyperpolarization (Patel et al. 1999; Plant 2012). The mechanism of action, however, is not fully understood but some evidence suggests it involves the C-terminal domain. In addition, halogenated anesthetics could disrupt the inhibitory influence of the Gq/G11 (Chen et al. 2006).
Selective serotonin reuptake inhibitors (SSRI) fluoxetine and norfluoxetine inhibit TREK1-TREK2 throughout the lateral portals, as visualized in the TREK2 structure (Dong et al. 2015). Interestingly, some clinical studies have described analgesic activity as a side effect of these antidepressants, which can be explained by their influence on K2P channels (Kennard et al. 2005), which is puzzling to explain since the inhibition of K2P channels is expected to increase pain. For example, fenamates are nonsteroidal anti-inflammatory drugs that selectively activate lipid-sensitive mechano-gated K2P channels, which is, together with the inhibition of pro-excitatory ion channels, the mechanism of analgesic action (Takahira et al. 2005). Fenamates exert their influence by interacting with the N-terminus of K2P channels (Veale et al. 2014). Finally, new compounds, like arylsulfonamide, ML335 and the thiophene-carboxamide ML402, have been reported as activators of TREK1,2/TRAAK (Lolicato et al. 2017).
8 Physiology and Function
Potassium channels support a wide array of functions within the body and the brain. Due to the extensive diversity of the K+ channel family, a discussion of the roles all these channels play in physiology and function is beyond the scope of this chapter. Instead, we will describe examples for each of the four general K+ channel families.
Kv channels most notably play a role in the excitability of neurons and help shape action potentials. Kv1.1 is one of the most abundant Kv1 subunits expressed in mammalian brain (Trimmer and Rhodes 2004) and often exists as part of a heteromeric channel complex (Rhodes et al. 1997). Kv1.1 associates with Kv1.2 at axon initial segments (Dodson et al. 2002; Inda et al. 2006; Van Wart et al. 2007), where they control synaptic efficacy via modulation of the action potential (Kole et al. 2007). The role of these channels in controlling neuronal excitability was revealed using venom toxins such as dendrotoxin, which can elicit seizures in rodents (Bagetta et al. 1992). In addition, mice lacking Kv1.1 are predisposed to seizures and exhibit spontaneous seizures and changes in CNS structure (Smart et al. 1998). In humans, several loss-of-function mutations have been identified that have been linked to episodic ataxia, myokymia disorders, and partial seizures (Zuberi et al. 1999). In addition to direct loss of Kv1.1 channel function, mutations in a protein that co-expresses with Kv1.1, the leucine-rich glioma-inactivated protein 1 (LGI1), have been associated with temporal lobe epilepsy (Schulte et al. 2006). In these examples, errant changes in action potential firing frequency can lead to various neurological and psychological disorders such as epilepsy. Targeting Kv1.1 subunit containing channels with some form of intervention could rescue the increased likelihood of seizures and epileptiform activity observed in humans with loss-of-function mutations.
Kv11.1 channels, often referred to as human ether-a-go-go (hERG) channels (Kaplan and Trout 3rd 1969), are particularly important in heart tissue. There are two kinetically distinct components of the delayed rectifier potassium current observed in cardiac myocytes, referred to as the rapid delayed rectifier (IKr) and the slow delayed rectifier (IKs) (Noble and Tsien 1969a, b). These two components are sufficient to account for cardiac repolarization (Noble and Tsien 1969b). IKr is mediated by Kv11.1 and displays a telltale “hook” characteristic of these channels when being recorded during deactivation (Shibasaki 1987). In cardiac cells, the slow activation and deactivation kinetics of Kv11.1 coupled with rapid voltage-dependent inactivation and recovery from inactivation make the current that passes through the channels ideal for determining the duration of plateau phase of atrial and ventricular myocyte action potentials (Sanguinetti et al. 1995; Smith et al. 1996) (Fig. 4). The maintenance of this plateau is critical for ensuring sufficient time for Ca2+ release from the sarcoplasm to enable cardiac contraction, and Kv11.1 current contributes to pacemaking activity of the sinoatrial and atrioventricular node cells (Clark et al. 2004; Furukawa et al. 1999; Mitcheson and Hancox 1999). Kv11.1 is the molecular target for most drugs that cause drug-induced arrhythmias (Sanguinetti et al. 1995), many of which require channel opening prior to gaining access to receptor site within the inner cavity of the channel pore (Carmeliet 1992; Kiehn et al. 1996; Yang et al. 1995). All clinical compounds developed need to be screened for off-target activity on Kv11.1 channel, which could potentially result in arrhythmias. Mutations in the KCNH2 gene that encodes Kv11.1 underlies chromosome 7-associated long QT syndrome (LQTS type 2), accounting for roughly 40% of cases of genetically confirmed LQTS (Fig. 4).
In all genotypes that produce long QT intervals there are some common traits: they occur at an early onset and LQTS carries an increased risk for sudden cardiac arrest (SCA) (Priori et al. 2003). Individuals with LQTS exhibit disruptions in T-wave morphology that are characteristic for different subtypes of LQTS (type 1, 2, and 3) (Moss et al. 1995; Zhang et al. 2000). Disruptions in T-waves may not be apparent at rest, especially in individuals with type 2 LQTS, who develop a bifid or notched T-wave appearance during exercise (Takenaka et al. 2003). It is still unknown why reduced Kv11.1 function presents with this bifid or notched T-wave pattern; however, some initial evidence suggests this phenotype may be due to an increase in transmural dispersion of repolarization in cardiac myocytes when Kv11.1 current is reduced (Shimizu and Antzelevitch 2000). With LQTS different behaviors are most associated with negative cardiac events or SCA. For type 1, exercise is the primary risk factor (62% of individuals), arousal is the primary trigger (43%) for type 2, and rest or sleep is the most common trigger (49%) for type 3 (Schwartz et al. 2001). While risk factors have been well defined and tools like EKG (Fig. 4) can be used to diagnose individuals, there is still limited understanding of the influence common polymorphisms of the KCNH2 gene can play in the disorder.
In contrast to LQTS, short QT syndrome (SQTS) is a disorder with a shortened duration of the QT interval on an electrocardiogram. This disorder is usually accompanied by atrial fibrillation (Patel et al. 2010). Like LQTS, SQTS appears to arise from mutations in the KCNH2 (Zhang et al. 2011) which result in reduced inactivation and a greater current flow during the plateau of the cardiac potential (Fig. 4), leading to the ventricular and atrial action potential having a shorter duration and a shortening of the QT interval and predispose the individual to sudden cardiac death (Brugada et al. 2004). More on cardiac K+ channels can be found in chapters “Cardiac K+ Channels and Channelopathies” and “Cardiac hERG K+ Channel as Safety and Pharmacological Target”.
KCa channels are widely expressed in both neuronal and non-neuronal tissues, where they play a diversity of physiological roles that are based on their ability to couple membrane potential and the intracellular Ca2+ concentration (Berkefeld et al. 2010). Increases in [Ca2+]i lead to an outward K+ flux through KCa channels that contributes to cell hyperpolarization. This helps to maintain Ca2+ homeostasis, limiting Ca2+ influx either through voltage-gated Ca2+ channel inactivation or increasing the activity of Na+/Ca2+ exchangers (Fakler and Adelman 2008). KCa1.1 channels (BK channels) are mainly expressed with β1 subunits in the vascular smooth muscle (Latorre et al. 2017), where these play a key role in the regulation of the vascular tone (Brenner et al. 2000b; Latorre et al. 2017). Ca2+ release from the sarcoplasmic reticulum forms Ca2+ sparks that activate BK channels, inducing vasodilation (Latorre et al. 2017; Pluger et al. 2000). The dysfunction of KCa1.1 channels or β1 mutations is involved in altered vasoregulation, such as hypertension (Dogan et al. 2019; Latorre et al. 2017). KCa1.1 expression has also been described in the intercalated cells of the kidney, in complex with either β1 or β4 subunits, where they participate in K+ secretion (Holtzclaw et al. 2011). Importantly, KCa1.1 channels are abundant and broadly found in the CNS (Sausbier et al. 2006), where they mainly associate with β4 subunits (Weiger et al. 2000). In neurons, KCa1.1 channels contribute to different processes involved in neuronal excitability, such as AP repolarization (Storm 1987), mediation of the fast phase of the AHP (Gu et al. 2007; Lancaster and Nicoll 1987; Storm 1987) and shaping the Ca2+ dendritic spikes (Golding et al. 1999), as well as to the modulation of neurotransmitter release (Griguoli et al. 2016; Yazejian et al. 2000).
Of particular interest is the role of KCa1.1 channels expressed in the suprachiasmatic nuclei (SCN) in the regulation of the circadian rhythm (Fig. 4) (Meredith et al. 2006; Montgomery et al. 2013; Whitt et al. 2016). KCa1.1 expression and outward currents are increased during nighttime (Montgomery et al. 2013), decreasing SCN neuronal activity at night. This decrease in activity is essential to maintain the high amplitude of the neural activity pattern in the SCN that restricts locomotor activity to the appropriate phase (night) (Montgomery et al. 2013). In KCNMA1 (gene encoding KCa1.1) knockout mice, the SCN neural activity amplitude is lost, altering the SCN pacemaker function, and making mice more active during daytime (Meredith et al. 2006) (Fig. 4).
KCa3.1 expression has been observed in diverse set of cells, including epithelial, vascular endothelial, vascular smooth muscle cells (Wulff and Castle 2010), hematopoietic cells, such as erythrocytes, lymphocytes, monocytes, and macrophages (Logsdon et al. 1997), and in CNS-resident immune cells, namely microglia (D’Alessandro et al. 2018; Ferreira et al. 2014). KCa3.1 plays an essential role in regulating cellular volume (Sforna et al. 2018), mediating the Ca2 + -dependent K+ efflux that is part of the regulatory volume decrease (RVD) that occurs upon cell swelling (Sforna et al. 2018; Vandorpe et al. 1998). This regulation of cellular volume links KCa3.1 channels with cell migration, since volume increases in one edge for protrusion and decreases for retraction (D’Alessandro et al. 2018). Interestingly, this role of KCa3.1 channels also accounts for their involvement in glioblastoma multiforme, where KCa3.1 is necessary for cell infiltration, and which expression correlates with worse prognosis (D’Alessandro et al. 2018; Turner et al. 2014).
Kir channels are widely expressed throughout the organism, playing a variety of roles in different cells and tissues. Their characteristic inward rectification accounts for their contribution not only to the maintenance of the resting membrane potential in excitable cells (Hibino et al. 2010), but also to the preservation of ionic gradients in renal tissues (Welling 2016). The ATP sensitivity of Kir6.x channels (Terzic et al. 1995) accounts for their physiological role, coupling the cellular metabolism with the excitability of the membrane (Tinker et al. 2018). Several Kir6.x and SUR subunits combinations are expressed in different tissues (Hibino et al. 2010). Cardiac myocytes and skeletal muscle express Kir6.2/SUR2A, where they play a protective role against ischemia-reperfusion (Suzuki et al. 2002) and as linkers to glucose metabolism (Weik and Neumcke 1989), respectively. In vascular smooth muscle, the predominant isoform is Kir6.1/SUR2B (Aziz et al. 2014), which participates in the regulation of the vascular tone (Aziz et al. 2014). Kir6.2/SUR1 channels have been described in hypothalamic neurons (Ashford et al. 1990), where they play a role in coupling glucose metabolism to glucagon secretion (Miki et al. 2001), and also in pancreatic β cells (Fig. 4). In these cells, Kir6.2/SUR1 are key players in glucose homeostasis, linking glucose metabolism to insulin secretion (Ashcroft et al. 1984). An increase in glucose levels elevates intracellular ATP, which binds to SUR1 closing Kir6.2 channel pore (Fig. 4) and promoting β cell depolarization, with the subsequent increase of intracellular Ca2+ that leads to insulin secretion (Hibino et al. 2010). Importantly, mutations in Kir6.2 and SUR1 lead to a range of insulin secretion disorders (Fig. 4) (Remedi and Koster 2010). Gain of function mutations are responsible for different types of neonatal diabetes (Gloyn et al. 2004) (Tinker et al. 2018), while loss of function mutations in both Kir6.2 and SUR1 cause congenital hyperinsulinism and hypoglycemia (Nestorowicz et al. 1997; Tinker et al. 2018). Sulfonylureas block Kir6.2 channels through their interaction with the SUR subunits and are commonly used for the treatment of diabetes (Ashcroft 2005).
In the case of Kir4.x and Kir5.1 channels, Kir4.1 homotetramers and Kir4.1/Kir5.1 heterotetramers are abundantly expressed in astrocytes (Hibino et al. 2004a) and in retinal Müller glial cells (Ishii et al. 2003), where they play an essential role in the spatial buffering extracellular K+, helping maintain the osmotic balance (Hibino et al. 2004a; Ishii et al. 2003). Kir4.1/Kir5.1 and Kir4.2/Kir5.1 channels have also been found in the kidney, particularly in the basolateral surface of renal epithelial cells (Lourdel et al. 2002; Tanemoto et al. 2000), where they contribute to the maintenance of the driving force required for Na+ reabsorption by recycling K+ across the basolateral membrane (Huang et al. 2007; Palygin et al. 2017). Moreover, Kir4.1/5.1 is also expressed in the cochlea of the inner ear (Hibino et al. 1997, 2004b), contributing to the generation of the endocochlear potential of the inner ear endolymph (Hibino and Kurachi 2006). Mutations in Kir4.1 lead to the SeSAME syndrome (Scholl et al. 2009), with a symptomatology characterized by seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME), that correlates with Kir4.1 expression in the organism (Scholl et al. 2009).
K2P channels are expressed in motoneurons (Berg et al. 2004; Talley et al. 2000), dorsal root ganglion (DRG) neurons (Kang and Kim 2006; Pereira et al. 2014), cortical, hippocampal, hypothalamic neurons (Fink et al. 1996; Medhurst et al. 2001), cerebellar granule neurons (Plant et al. 2002) and cortical astrocytes (Hwang et al. 2014). In particular, K2P channels in the DRG control the generation of an action potential through thermal-gating of TREK2 (Fig. 4). TREK2 increases K+ outflow in response to heat, within the 24–42°C range (Kang et al. 2005). Nociceptive neurons in the DRGs that innervate most of the body surface express TREK2, which regulates non-aversive warmth perception. In a wild-type individual, heat-sensitive c-fibers increase their firing activity gradually as they approach 42°C, due to the activation of mainly thermosensitive transient receptor potential (TRP) channels (Caterina et al. 1997). However, in mice lacking TREK2, the number of action potentials significantly increases by 30% in the 30–40°C range compared to wild type. Additionally, TREK2−/− mice exhibit hyperalgesia, since tail flick latencies upon 40 and 42°C bath immersion are reduced (Pereira et al. 2014) (Fig. 4). Overall, the channel, neuron, and animal behavior indicate the following: TREK2 by being active with heat contributes to a hyperpolarizing environment in the nociceptive neurons which dampen nociceptive signals upon non-aversive warmth.
K2P malfunctioning has been extensively associated to different pain manifestations such as neuropathic pain or migraine. TRESK also contributes to background current in DRG neurons (Plant 2012; Tulleuda et al. 2011). TRESK is downregulated in spared nerve injury (SNI) model of chronic pain in rats. Interestingly, the hyperalgesia and gliocytes activation are reduced after inducing recombinant TRESK gene overexpression (Zhou et al. 2017). TWIK1 and TASK3 are also reduced in SNI. However, their levels are restored after weeks in the case of TWIK1 and months for TASK3 (Pollema-Mays et al. 2013). Multiple TRESK mutations in humans have been associated to migraine with aura (Lafreniere et al. 2010; Rainero et al. 2014). Proximal point mutations in regions close to the pore (i.e., A34V and C110R) lead to smaller TRESK currents (Andres-Enguix et al. 2012). TRESK deletions display dominant-negative phenotype in heterologous systems when is co-expressed with wild-type TRESK (Lafreniere and Rouleau 2011). Together, these studies suggest TRESK as a target for new analgesics.
A noteworthy contribution of the K2P channels in the brain is their implication on glutamate release from astrocytes. Classically, neurons have been exclusively attributed for fast glutamatergic synaptic transmission. However, recent studies have shown astrocytes induce slow and fast glutamate release, involving mechanisms of neuron-like exocytosis or transporter/channel mediated. Astrocytes display a leaky membrane with a low resistance, attributed to primarily the outwardly rectifier TREK1 (Fink et al. 1996). Activation of TREK1, either directly or upon CB1 activation Gβγ to the N-terminal, induces astrocytic glutamate release (Woo et al. 2012). TREK1 downregulation eliminates glutamate release fast mode but does not affect the slow mode. Interestingly, the “non-functional” TWIK1 is also expressed in astrocytes and forms a functional heteromer with TREK1 (Hwang et al. 2014).
Abbreviations
- EKG:
-
Electrocardiogram
- GIRK:
-
G protein-gated inwardly rectifying potassium channel
- KATP:
-
ATP-sensitive inwardly rectifying potassium channel
- TALK:
-
Two-pore ALkaline-activated K+ channel
- TASK:
-
Two-pore acid-sensitive K+ channel
- THIK:
-
Two-pore halothane-inhibited K+ channel
- TRAAK:
-
TWIK-related arachidonic acid-stimulated K+ channel
- TREK:
-
TWIK-related K+ channel
- TRESK:
-
TWIK-related spinal-cord K+ channel
- TWIK:
-
Two-pore weak inward-rectifying K+ channel
References
Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptacek LJ, Goldstein SAN (2001) MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104:217–231
Abbott GW, Butler MH, Goldstein SAN (2006) Phosphorylation and protonation of neighboring MiRP2 sites: function and pathophysiology of MiRP2-Kv3.4 potassium channels in periodic paralysis. FASEB J 20:293–301
Adelman JP (2016) SK channels and calmodulin. Channels (Austin) 10:1–6
Adelman JP, Maylie J, Sah P (2012) Small-conductance Ca2+−activated K+ channels: form and function. Annu Rev Physiol 74:245–269
A-González N, Castrillo A (2011) Liver X receptors as regulators of macrophage inflammatory and metabolic pathways. Biochim Biophys Acta (BBA) Mol Basis Dis 1812:982–994
Aguilar-Bryan L, Clement JPt, Gonzalez G, Kunjilwar K, Babenko A, Bryan J (1998) Toward understanding the assembly and structure of KATP channels. Physiol Rev 78:227–245
Ahern CA, Horn R (2004) Specificity of charge-carrying residues in the voltage sensor of potassium channels. J Gen Physiol 123:205–216
Ahern CA, Horn R (2005) Focused electric field across the voltage sensor of potassium channels. Neuron 48:25–29
Albrecht B, Weber K, Pongs O (1995) Characterization of a voltage-activated K-channel gene cluster on human chromosome 12p13. Receptors Channels 3:213–220
Aldrich RW (2001) Fifty years of inactivation. Nature 411:643–644
Allen D, Fakler B, Maylie J, Adelman JP (2007) Organization and regulation of small conductance Ca2+−activated K+ channel multiprotein complexes. J Neurosci 27:2369–2376
Al-Sabi A, Lennartz D, Ferber M, Gulyas J, Rivier JEF, Olivera BM, Carlomagno T, Terlau H (2004) κM-conotoxin RIIIK, structural and functional novelty in a K+channel antagonist†. Biochemistry 43:8625–8635
Anazco C, Pena-Munzenmayer G, Araya C, Cid LP, Sepulveda FV, Niemeyer MI (2013) G protein modulation of K2P potassium channel TASK-2: a role of basic residues in the C terminus domain. Pflügers Arch 465:1715–1726
Anderson NJ, Slough S, Watson WP (2006) In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant. Eur J Pharmacol 546:48–53
Andres-Enguix I, Shang L, Stansfeld PJ, Morahan JM, Sansom MS, Lafreniere RG, Roy B, Griffiths LR, Rouleau GA, Ebers GC et al (2012) Functional analysis of missense variants in the TRESK (KCNK18) K channel. Sci Rep 2:237
Åqvist J, Luzhkov V (2000) Ion permeation mechanism of the potassium channel. Nature 404:881–884
Ashcroft FM (2005) ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115:2047–2058
Ashcroft FM, Harrison DE, Ashcroft SJ (1984) Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 312:446–448
Ashfield R, Gribble FM, Ashcroft SJ, Ashcroft FM (1999) Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes 48:1341–1347
Ashford ML, Boden PR, Treherne JM (1990) Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels. Pflugers Arch 415:479–483
Augustine GJ, Santamaria F, Tanaka K (2003) Local calcium signaling in neurons. Neuron 40:331–346
Aziz Q, Thomas AM, Gomes J, Ang R, Sones WR, Li Y, Ng KE, Gee L, Tinker A (2014) The ATP-sensitive potassium channel subunit, Kir6.1, in vascular smooth muscle plays a major role in blood pressure control. Hypertension 64:523–529
Bagetta G, Nistico G, Dolly JO (1992) Production of seizures and brain damage in rats by alpha-dendrotoxin, a selective K+ channel blocker. Neurosci Lett 139:34–40
Bagriantsev SN, Peyronnet R, Clark KA, Honore E, Minor DL Jr (2011) Multiple modalities converge on a common gate to control K2P channel function. EMBO J 30:3594–3606
Baker OS, Larsson HP, Mannuzzu LM, Isacoff EY (1998) Three transmembrane conformations and sequence-dependent displacement of the S4 domain in shaker K+ channel gating. Neuron 20:1283–1294
Baronas VA, Kurata HT (2014) Inward rectifiers and their regulation by endogenous polyamines. Front Physiol 5:325
Baukrowitz T, Schulte U, Oliver D, Herlitze S, Krauter T, Tucker SJ, Ruppersberg JP, Fakler B (1998) PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science 282:1141–1144
Behrens R, Nolting A, Reimann F, Schwarz M, Waldschutz R, Pongs O (2000) hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel beta subunit family. FEBS Lett 474:99–106
Bentrop D, Beyermann M, Wissmann R, Fakler B (2001) NMR structure of the "ball-and-chain" domain of KCNMB2, the beta 2-subunit of large conductance Ca2+− and voltage-activated potassium channels. J Biol Chem 276:42116–42121
Berg AP, Talley EM, Manger JP, Bayliss DA (2004) Motoneurons express heteromeric TWIK-related acid-sensitive K+ (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits. J Neurosci 24:6693–6702
Berkefeld H, Sailer CA, Bildl W, Rohde V, Thumfart JO, Eble S, Klugbauer N, Reisinger E, Bischofberger J, Oliver D et al (2006) BKCa-Cav channel complexes mediate rapid and localized Ca2+−activated K+ signaling. Science 314:615–620
Berkefeld H, Fakler B, Schulte U (2010) Ca2+−activated K+ channels: from protein complexes to function. Physiol Rev 90:1437–1459
Bernèche S, Roux B (2001) Energetics of ion conduction through the K+ channel. Nature 414:73–77
Bezanilla F (2000) The voltage sensor in voltage-dependent ion channels. Physiol Rev 80:555–592
Bichet D, Haass FA, Jan LY (2003) Merging functional studies with structures of inward-rectifier K(+) channels. Nat Rev Neurosci 4:957–967
Bildl W, Strassmaier T, Thurm H, Andersen J, Eble S, Oliver D, Knipper M, Mann M, Schulte U, Adelman JP et al (2004) Protein kinase CK2 is coassembled with small conductance ca(2+)-activated K+ channels and regulates channel gating. Neuron 43:847–858
Blatz AL, Magleby KL (1984) Ion conductance and selectivity of single calcium-activated potassium channels in cultured rat muscle. J Gen Physiol 84:1–23
Bockenhauer D, Zilberberg N, Goldstein SA (2001) KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. Nat Neurosci 4:486–491
Brenner R, Jegla TJ, Wickenden A, Liu Y, Aldrich RW (2000a) Cloning and functional characterization of novel large conductance calcium-activated potassium channel beta subunits, hKCNMB3 and hKCNMB4. J Biol Chem 275:6453–6461
Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, Aldrich RW (2000b) Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 407:870–876
Brereton MF, Ashcroft FM (2013) Mouse models of beta-cell KATP channel dysfunction. Drug Discov Today Dis Models 10:e101–e109
Bretschneider F, Wrisch A, Lehmann-Horn F, Grissmer S (1999) External tetraethylammonium as a molecular caliper for sensing the shape of the outer vestibule of potassium channels. Biophys J 76:2351–2360
Brohawn SG, del Marmol J, MacKinnon R (2012) Crystal structure of the human K2P TRAAK, a lipid- and mechano-sensitive K+ ion channel. Science 335:436–441
Brohawn SG, Campbell EB, MacKinnon R (2014) Physical mechanism for gating and mechanosensitivity of the human TRAAK K+ channel. Nature 516:126–130
Broomand A, Elinder F (2008) Large-scale movement within the voltage-sensor paddle of a potassium channel-support for a helical-screw motion. Neuron 59:770–777
Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M, Menendez TM, Brugada J, Pollevick GD, Wolpert C et al (2004) Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109:30–35
Bukiya AN, Liu J, Toro L, Dopico AM (2007) Beta1 (KCNMB1) subunits mediate lithocholate activation of large-conductance Ca2+−activated K+ channels and dilation in small, resistance-size arteries. Mol Pharmacol 72:359–369
Bukiya AN, McMillan J, Liu J, Shivakumar B, Parrill AL, Dopico AM (2014) Activation of calcium- and voltage-gated potassium channels of large conductance by leukotriene B4. J Biol Chem 289:35314–35325
Butler A, Tsunoda S, McCobb DP, Wei A, Salkoff L (1993) mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. Science 261:221–224
Cao Y, Dreixler JC, Roizen JD, Roberts MT, Houamed KM (2001) Modulation of recombinant small-conductance ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds. J Pharmacol Exp Ther 296:683–689
Carmeliet E (1992) Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 262:809–817
Casamassima M, D'Adamo MC, Pessia M, Tucker SJ (2003) Identification of a heteromeric interaction that influences the rectification, gating, and pH sensitivity of Kir4.1/Kir5.1 potassium channels. J Biol Chem 278:43533–43540
Castle NA, London DO, Creech C, Fajloun Z, Stocker JW, Sabatier JM (2003) Maurotoxin: a potent inhibitor of intermediate conductance Ca2+−activated potassium channels. Mol Pharmacol 63:409–418
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824
Chakrapani S, Cuello LG, Cortes DM, Perozo E (2008) Structural dynamics of an isolated voltage-sensor domain in a lipid bilayer. Structure 16:398–409
Chatelain FC, Bichet D, Douguet D, Feliciangeli S, Bendahhou S, Reichold M, Warth R, Barhanin J, Lesage F (2012) TWIK1, a unique background channel with variable ion selectivity. Proc Natl Acad Sci U S A 109:5499–5504
Chemin J, Patel AJ, Duprat F, Lauritzen I, Lazdunski M, Honore E (2005) A phospholipid sensor controls mechanogating of the K+ channel TREK-1. EMBO J 24:44–53
Chemin J, Patel AJ, Duprat F, Sachs F, Lazdunski M, Honore E (2007) Up- and down-regulation of the mechano-gated K(2P) channel TREK-1 by PIP (2) and other membrane phospholipids. Pflügers Arch 455:97–103
Chen X, Talley EM, Patel N, Gomis A, McIntire WE, Dong B, Viana F, Garrison JC, Bayliss DA (2006) Inhibition of a background potassium channel by Gq protein alpha-subunits. Proc Natl Acad Sci U S A 103:3422–3427
Clark RB, Mangoni ME, Lueger A, Couette B, Nargeot J, Giles WR (2004) A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells. Am J Physiol Heart Circ Physiol 286:H1757–H1766
Clarke OB, Caputo AT, Hill AP, Vandenberg JI, Smith BJ, Gulbis JM (2010) Domain reorientation and rotation of an intracellular assembly regulate conduction in Kir potassium channels. Cell 141:1018–1029
Clement JPt, Kunjilwar K, Gonzalez G, Schwanstecher M, Panten U, Aguilar-Bryan L, Bryan J (1997) Association and stoichiometry of K(ATP) channel subunits. Neuron 18:827–838
Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, Morena H, Nadal MS, Ozaita A, Pountney D et al (1999) Molecular diversity of K+ channels. Ann N Y Acad Sci 868:233–255
Cohen A, Ben-Abu Y, Hen S, Zilberberg N (2008) A novel mechanism for human K2P2.1 channel gating. Facilitation of C-type gating by protonation of extracellular histidine residues. J Biol Chem 283:19448–19455
Coleman SK, Newcombe J, Pryke J, Dolly JO (1999) Subunit composition of Kv1 channels in human CNS. J Neurochem 73:849–858
Cuello LG (2004) Molecular architecture of the KvAP voltage-dependent K+ channel in a lipid bilayer. Science 306:491–495
Cui J (2016) Voltage-dependent gating: novel insights from KCNQ1 channels. Biophys J 110:14–25
Cui J, Cox DH, Aldrich RW (1997) Intrinsic voltage dependence and Ca2+ regulation of mslo large conductance ca-activated K+ channels. J Gen Physiol 109:647–673
Czirjak G, Enyedi P (2002) Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J Biol Chem 277:5426–5432
D’Alessandro G, Limatola C, Catalano M (2018) Functional roles of the Ca2+−activated K+ channel, KCa3.1, in brain tumors. Curr Neuropharmacol 16:636–643
Dauplais M, Lecoq A, Song J, Cotton J, Jamin N, Gilquin B, Roumestand C, Vita C, De Medeiros CLC, Rowan EG et al (1997) On the convergent evolution of animal toxins. J Biol Chem 272:4302–4309
Devor DC, Singh AK, Frizzell RA, Bridges RJ (1996) Modulation of cl- secretion by benzimidazolones. I. Direct activation of a ca(2+)-dependent K+ channel. Am J Phys 271:L775–L784
Diaz L, Meera P, Amigo J, Stefani E, Alvarez O, Toro L, Latorre R (1998) Role of the S4 segment in a voltage-dependent calcium-sensitive potassium (hSlo) channel. J Biol Chem 273:32430–32436
Dodson PD, Barker MC, Forsythe ID (2002) Two heteromeric Kv1 potassium channels differentially regulate action potential firing. J Neurosci 22:6953–6961
Dogan MF, Yildiz O, Arslan SO, Ulusoy KG (2019) Potassium channels in vascular smooth muscle: a pathophysiological and pharmacological perspective. Fundam Clin Pharmacol 33:504–523
Dong YY, Pike AC, Mackenzie A, McClenaghan C, Aryal P, Dong L, Quigley A, Grieben M, Goubin S, Mukhopadhyay S et al (2015) K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac. Science 347:1256–1259
Dopico AM, Bukiya AN (2017) Regulation of ca(2+)-sensitive K(+) channels by cholesterol and bile acids via distinct channel subunits and sites. Curr Top Membr 80:53–93
Doring F, Derst C, Wischmeyer E, Karschin C, Schneggenburger R, Daut J, Karschin A (1998) The epithelial inward rectifier channel Kir7.1 displays unusual K+ permeation properties. J Neurosci 18:8625–8636
Doupnik CA (2017) Venom-derived peptides inhibiting Kir channels: past, present, and future. Neuropharmacology 127:161–172
Doyle ME, Egan JM (2003) Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev 55:105–131
Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT, MacKinnon R (1998) The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 280:69–77
Du X, Zhang H, Lopes C, Mirshahi T, Rohacs T, Logothetis DE (2004) Characteristic interactions with phosphatidylinositol 4,5-bisphosphate determine regulation of kir channels by diverse modulators. J Biol Chem 279:37271–37281
Dworetzky SI, Boissard CG, Lum-Ragan JT, McKay MC, Post-Munson DJ, Trojnacki JT, Chang CP, Gribkoff VK (1996) Phenotypic alteration of a human BK (hSlo) channel by hSlobeta subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase A modulation. J Neurosci 16:4543–4550
Eriksson MAL, Roux B (2002) Modeling the structure of agitoxin in complex with the shaker K+ channel: a computational approach based on experimental distance restraints extracted from thermodynamic mutant cycles. Biophys J 83:2595–2609
Fakler B, Adelman JP (2008) Control of K(ca) channels by calcium nano/microdomains. Neuron 59:873–881
Fanger CM, Ghanshani S, Logsdon NJ, Rauer H, Kalman K, Zhou J, Beckingham K, Chandy KG, Cahalan MD, Aiyar J (1999) Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel. IKCa1 J Biol Chem 274:5746–5754
Ferreira R, Lively S, Schlichter LC (2014) IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia. Front Cell Neurosci 8:183
Fink M, Duprat F, Lesage F, Reyes R, Romey G, Heurteaux C, Lazdunski M (1996) Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. EMBO J 15:6854–6862
Finley M, Arrabit C, Fowler C, Suen KF, Slesinger PA (2004) betaL-betaM loop in the C-terminal domain of G protein-activated inwardly rectifying K(+) channels is important for G(betagamma) subunit activation. J Physiol 555:643–657
Finol-Urdaneta RK, StrüVer N, Terlau H (2006) Molecular and functional differences between heart mKv1.7 channel isoforms. J Gen Physiol 128:133–145
Finol-Urdaneta RK, Belovanovic A, Micic-Vicovac M, Kinsella GK, McArthur JR, Al-Sabi A (2020) Marine toxins targeting Kv1 channels: pharmacological tools and therapeutic scaffolds. Mar Drugs 18:173
Forte M, Satow Y, Nelson D, Kung C (1981) Mutational alteration of membrane phospholipid composition and voltage-sensitive ion channel function in paramecium. Proc Natl Acad Sci 78:7195–7199
Furukawa Y, Miyashita Y, Nakajima K, Hirose M, Kurogouchi F, Chiba S (1999) Effects of verapamil, zatebradine, and E-4031 on the pacemaker location and rate in response to sympathetic stimulation in dog hearts. J Pharmacol Exp Ther 289:1334–1342
Gada K, Plant LD (2019) Two-pore domain potassium channels: emerging targets for novel analgesic drugs: IUPHAR review 26. Br J Pharmacol 176:256–266
Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ, Garcia ML (1990) Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 265:11083–11090
Gandhi CS, Isacoff EY (2002) Molecular models of voltage sensing. J Gen Physiol 120:455–463
Gao Y-D, Garcia ML (2003) Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and maxi-K channels. Proteins Struct Funct Genet 52:146–154
Garcia-Valdes J, Zamudio FZ, Toro L, Possani LD (2001) Slotoxin, alphaKTx1.11, a new scorpion peptide blocker of MaxiK channels that differentiates between alpha and alpha+beta (beta1 or beta4) complexes. FEBS Lett 505:369–373
Gardos G (1958) The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 30:653–654
Gilquin B, Racapé J, Wrisch A, Visan V, Lecoq A, Grissmer S, Ménez A, Gasparini S (2002) Structure of the BgK-Kv1.1 complex based on distance restraints identified by double mutant cycles. J Biol Chem 277:37406–37413
Girard CA, Wunderlich FT, Shimomura K, Collins S, Kaizik S, Proks P, Abdulkader F, Clark A, Ball V, Zubcevic L et al (2009) Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes. J Clin Invest 119:80–90
Glaaser IW, Slesinger PA (2017) Dual activation of neuronal G protein-gated inwardly rectifying potassium (GIRK) channels by cholesterol and alcohol. Sci Rep 7:4592
Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838–1849
Golding NL, Jung HY, Mickus T, Spruston N (1999) Dendritic calcium spike initiation and repolarization are controlled by distinct potassium channel subtypes in CA1 pyramidal neurons. J Neurosci 19:8789–8798
Goldstein SA, Price LA, Rosenthal DN, Pausch MH (1996) ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 93:13256–13261
Goldstein SA, Bockenhauer D, O'Kelly I, Zilberberg N (2001) Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci 2:175–184
Gonzalez-Perez V, Xia XM, Lingle CJ (2014) Functional regulation of BK potassium channels by gamma1 auxiliary subunits. Proc Natl Acad Sci U S A 111:4868–4873
Gonzalez-Perez V, Xia XM, Lingle CJ (2015) Two classes of regulatory subunits coassemble in the same BK channel and independently regulate gating. Nat Commun 6:8341
Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR (2009) Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 373:732–738
Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K et al (2001) Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 7:471–477
Griguoli M, Sgritta M, Cherubini E (2016) Presynaptic BK channels control transmitter release: physiological relevance and potential therapeutic implications. J Physiol 594:3489–3500
Grover GJ, Garlid KD (2000) ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32:677–695
Grunnet M, Kaufmann WA (2004) Coassembly of big conductance Ca2+−activated K+ channels and L-type voltage-gated Ca2+ channels in rat brain. J Biol Chem 279:36445–36453
Grunnet M, Jensen BS, Olesen SP, Klaerke DA (2001) Apamin interacts with all subtypes of cloned small-conductance Ca2+−activated K+ channels. Pflugers Arch 441:544–550
Gu C, Gu Y (2011) Clustering and activity tuning of Kv1 channels in myelinated hippocampal axons. J Biol Chem 286:25835–25847
Gu N, Vervaeke K, Storm JF (2007) BK potassium channels facilitate high-frequency firing and cause early spike frequency adaptation in rat CA1 hippocampal pyramidal cells. J Physiol 580:859–882
Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W et al (2005) International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 57:473–508
Hagiwara S, Miyazaki S, Rosenthal NP (1976) Potassium current and the effect of cesium on this current during anomalous rectification of the egg cell membrane of a starfish. J Gen Physiol 67:621–638
Hagiwara S, Miyazaki S, Moody W, Patlak J (1978) Blocking effects of barium and hydrogen ions on the potassium current during anomalous rectification in the starfish egg. J Physiol 279:167–185
Hanner M, Schmalhofer WA, Munujos P, Knaus HG, Kaczorowski GJ, Garcia ML (1997) The beta subunit of the high-conductance calcium-activated potassium channel contributes to the high-affinity receptor for charybdotoxin. Proc Natl Acad Sci U S A 94:2853–2858
Hansen SB, Tao X, MacKinnon R (2011) Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature 477:495–498
Harvey AL, Anderson AJ (1985) Dendrotoxins: snake toxins that block potassium channels and facilitate neurotransmitter release. Pharmacol Ther 31:33–55
Harvey AL, Robertson B (2004) Dendrotoxins: structure-activity relationships and effects on potassium ion channels. Curr Med Chem 11:3065–3072
He C, Zhang H, Mirshahi T, Logothetis DE (1999) Identification of a potassium channel site that interacts with G protein bg subunits to mediate agonist-induced signaling. J Biol Chem 274:12517–12524
Hebert B, Pietropaolo S, Meme S, Laudier B, Laugeray A, Doisne N, Quartier A, Lefeuvre S, Got L, Cahard D et al (2014) Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule. Orphanet J Rare Dis 9:124
Heginbotham L, Lu Z, Abramson T, MacKinnon R (1994) Mutations in the K+ channel signature sequence. Biophys J 66:1061–1067
Hibino H, Kurachi Y (2006) Molecular and physiological bases of the K+ circulation in the mammalian inner ear. Physiology (Bethesda) 21:336–345
Hibino H, Horio Y, Inanobe A, Doi K, Ito M, Yamada M, Gotow T, Uchiyama Y, Kawamura M, Kubo T et al (1997) An ATP-dependent inwardly rectifying potassium channel, KAB-2 (Kir4. 1), in cochlear stria vascularis of inner ear: its specific subcellular localization and correlation with the formation of endocochlear potential. J Neurosci 17:4711–4721
Hibino H, Fujita A, Iwai K, Yamada M, Kurachi Y (2004a) Differential assembly of inwardly rectifying K+ channel subunits, Kir4.1 and Kir5.1, in brain astrocytes. J Biol Chem 279:44065–44073
Hibino H, Higashi-Shingai K, Fujita A, Iwai K, Ishii M, Kurachi Y (2004b) Expression of an inwardly rectifying K+ channel, Kir5.1, in specific types of fibrocytes in the cochlear lateral wall suggests its functional importance in the establishment of endocochlear potential. Eur J Neurosci 19:76–84
Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y (2010) Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90:291–366
Hille B (1986) Ionic channels: molecular pores of excitable membranes. Harvey Lect 82:47–69
Hirschberg B, Maylie J, Adelman JP, Marrion NV (1999) Gating properties of single SK channels in hippocampal CA1 pyramidal neurons. Biophys J 77:1905–1913
Hite RK, Tao X, MacKinnon R (2017) Structural basis for gating the high-conductance ca(2+)-activated K(+) channel. Nature 541:52–57
Ho IH, Murrell-Lagnado RD (1999) Molecular determinants for sodium-dependent activation of G protein-gated K+ channels. J Biol Chem 274:8639–8648
Hodgkin AL, Huxley AF (1945) Resting and action potentials in single nerve fibres. J Physiol 104:176–195
Holtzclaw JD, Grimm PR, Sansom SC (2011) Role of BK channels in hypertension and potassium secretion. Curr Opin Nephrol Hypertens 20:512–517
Horinaka S (2011) Use of nicorandil in cardiovascular disease and its optimization. Drugs 71:1105–1119
Horrigan FT, Aldrich RW (2002) Coupling between voltage sensor activation, Ca2+ binding and channel opening in large conductance (BK) potassium channels. J Gen Physiol 120:267–305
Horvath GA, Zhao Y, Tarailo-Graovac M, Boelman C, Gill H, Shyr C, Lee J, Blydt-Hansen I, Drogemoller BI, Moreland J et al (2018) Gain-of-function KCNJ6 mutation in a severe hyperkinetic movement disorder phenotype. Neuroscience 384:152–164
Hoshi T, Armstrong CM (2013) C-type inactivation of voltage-gated K+ channels: pore constriction or dilation? J Gen Physiol 141:151–160
Hoshi T, Wissuwa B, Tian Y, Tajima N, Xu R, Bauer M, Heinemann SH, Hou S (2013) Omega-3 fatty acids lower blood pressure by directly activating large-conductance ca(2)(+)-dependent K(+) channels. Proc Natl Acad Sci U S A 110:4816–4821
Hougaard C, Eriksen BL, Jorgensen S, Johansen TH, Dyhring T, Madsen LS, Strobaek D, Christophersen P (2007) Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+−activated K+ channels. Br J Pharmacol 151:655–665
Huang CL, Feng S, Hilgemann DW (1998) Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 391:803–806
Huang C, Sindic A, Hill CE, Hujer KM, Chan KW, Sassen M, Wu Z, Kurachi Y, Nielsen S, Romero MF et al (2007) Interaction of the Ca2+−sensing receptor with the inwardly rectifying potassium channels Kir4.1 and Kir4.2 results in inhibition of channel function. Am J Physiol Renal Physiol 292:F1073–F1081
Hughes BA, Kumar G, Yuan Y, Swaminathan A, Yan D, Sharma A, Plumley L, Yang-Feng TL, Swaroop A (2000) Cloning and functional expression of human retinal kir2.4, a pH-sensitive inwardly rectifying K(+) channel. Am J Physiol Cell Physiol 279:C771–C784
Hwang EM, Kim E, Yarishkin O, Woo DH, Han KS, Park N, Bae Y, Woo J, Kim D, Park M et al (2014) A disulphide-linked heterodimer of TWIK-1 and TREK-1 mediates passive conductance in astrocytes. Nat Commun 5:3227
Imlach WL, Finch SC, Dunlop J, Dalziel JE (2009) Structural determinants of lolitrems for inhibition of BK large conductance Ca2+−activated K+ channels. Eur J Pharmacol 605:36–45
Imredy JP, Chen C, MacKinnon R (1998) A snake toxin inhibitor of inward rectifier potassium channel ROMK1. Biochemistry 37:14867–14874
Inda MC, Defelipe J, Munoz A (2006) Voltage-gated ion channels in the axon initial segment of human cortical pyramidal cells and their relationship with chandelier. Cell 103:2920–2925
Ishida IG, Rangel-Yescas GE, Carrasco-Zanini J, Islas LD (2015) Voltage-dependent gating and gating charge measurements in the Kv1.2 potassium channel. J Gen Physiol 145:345–358
Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J (1997) A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A 94:11651–11656
Ishii M, Fujita A, Iwai K, Kusaka S, Higashi K, Inanobe A, Hibino H, Kurachi Y (2003) Differential expression and distribution of Kir5.1 and Kir4.1 inwardly rectifying K+ channels in retina. Am J Physiol Cell Physiol 285:C260–C267
Ivanina T, Rishal I, Varon D, Mullner C, Frohnwieser-Steinecke B, Schreibmayer W, Dessauer CW, Dascal N (2003) Mapping the Gβγ-binding sites in GIRK1 and GIRK2 subunits of the G protein-activated K+ channel. J Biol Chem 278:29174–29183
Jin W, Lu Z (1998) A novel high-affinity inhibitor for inward-rectifier K+ channels. Biochemistry 37:13291–13299
Jin W, Lu Z (1999) Synthesis of a stable form of tertiapin: a high-affinity inhibitor for inward-rectifier K+ channels. Biochemistry 38:14286–14293
Joiner WJ, Khanna R, Schlichter LC, Kaczmarek LK (2001) Calmodulin regulates assembly and trafficking of SK4/IK1 Ca2+−activated K+ channels. J Biol Chem 276:37980–37985
Jouirou B, Mouhat S, Andreotti N, De Waard M, Sabatier J-M (2004) Toxin determinants required for interaction with voltage-gated K+ channels. Toxicon 43:909–914
Kamath GS, Mittal S (2008) The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death. Prog Cardiovasc Dis 50:439–448
Kang D, Kim D (2006) TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons. Am J Physiol Cell Physiol 291:C138–C146
Kang D, Choe C, Kim D (2005) Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK. J Physiol 564:103–116
Kanjhan R, Coulson EJ, Adams DJ, Bellingham MC (2005) Tertiapin-Q blocks recombinant and native large conductance K+ channels in a use-dependent manner. J Pharmacol Exp Ther 314:1353–1361
Kaplan WD, Trout WE 3rd (1969) The behavior of four neurological mutants of Drosophila. Genetics 61:399–409
Kasumu AW, Hougaard C, Rode F, Jacobsen TA, Sabatier JM, Eriksen BL, Strobaek D, Liang X, Egorova P, Vorontsova D et al (2012) Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2. Chem Biol 19:1340–1353
Katz B (1949) Les Constantes Electriques De La Membrane Du Muscle. Arch Sci Physiol 3:285–300
Kaufmann K, Romaine I, Days E, Pascual C, Malik A, Yang L, Zou B, Du Y, Sliwoski G, Morrison RD et al (2013) ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice. ACS Chem Neurosci 4:1278–1286
Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL, Mathie A (2005) Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol 144:821–829
Ketchum KA, Joiner WJ, Sellers AJ, Kaczmarek LK, Goldstein SA (1995) A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem. Nature 376:690–695
Khalili-Araghi F, Tajkhorshid E, Schulten K (2006) Dynamics of K+ ion conduction through Kv1.2. Biophys J 91:L72–L74
Kiehn J, Wible B, Lacerda AE, Brown AM (1996) Mapping the block of a cloned human inward rectifier potassium channel by dofetilide. Mol Pharmacol 50:380–387
Kim Y, Bang H, Kim D (2000) TASK-3, a new member of the tandem pore K(+) channel family. J Biol Chem 275:9340–9347
King JT, Lovell PV, Rishniw M, Kotlikoff MI, Zeeman ML, McCobb DP (2006) Beta2 and beta4 subunits of BK channels confer differential sensitivity to acute modulation by steroid hormones. J Neurophysiol 95:2878–2888
Klein H, Garneau L, Trinh NT, Prive A, Dionne F, Goupil E, Thuringer D, Parent L, Brochiero E, Sauve R (2009) Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells. Am J Physiol Cell Physiol 296:C285–C295
Knaus HG, Folander K, Garcia-Calvo M, Garcia ML, Kaczorowski GJ, Smith M, Swanson R (1994a) Primary sequence and immunological characterization of beta-subunit of high conductance ca(2+)-activated K+ channel from smooth muscle. J Biol Chem 269:17274–17278
Knaus HG, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LM, Sanchez M, Giangiacomo K, Reuben JP, Smith AB 3rd et al (1994b) Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry 33:5819–5828
Kobayashi T, Ikeda K, Kojima H, Niki H, Yano R, Yoshioka T, Kumanishi T (1999) Ethanol opens G-protein-activated inwardly rectifying K+ channels. Nat Neurosci 2:1091–1097
Kohler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, Maylie J, Adelman JP (1996) Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273:1709–1714
Kole MHP, Stuart GJ (2012) Signal processing in the axon initial segment. Neuron 73:235–247
Kole MH, Letzkus JJ, Stuart GJ (2007) Axon initial segment Kv1 channels control axonal action potential waveform and synaptic efficacy. Neuron 55:633–647
Korenke AR, Rivey MP, Allington DR (2008) Sustained-release fampridine for symptomatic treatment of multiple sclerosis. Ann Pharmacother 42:1458–1465
Krapivinsky G, Medina I, Eng L, Krapivinsky L, Yang Y, Clapham DE (1998) A novel inward rectifier K+ channel with unique pore properties. Neuron 20:995–1005
Krepkiy D, Mihailescu M, Freites JA, Schow EV, Worcester DL, Gawrisch K, Tobias DJ, White SH, Swartz KJ (2009) Structure and hydration of membranes embedded with voltage-sensing domains. Nature 462:473–479
Kshatri AS, Gonzalez-Hernandez A, Giraldez T (2018) Physiological roles and therapeutic potential of ca(2+) activated potassium channels in the nervous system. Front Mol Neurosci 11:258
Kubo Y, Murata Y (2001) Control of rectification and permeation by two distinct sites after the second transmembrane region in Kir2.1 K+ channel. J Physiol 531:645–660
Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S, Vandenberg CA (2005) International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev 57:509–526
Kumar M, Pattnaik BR (2014) Focus on Kir7.1: physiology and channelopathy. Channels (Austin) 8:488–495
Kuo A, Gulbis JM, Antcliff JF, Rahman T, Lowe ED, Zimmer J, Cuthbertson J, Ashcroft FM, Ezaki T, Doyle DA (2003) Crystal structure of the potassium channel KirBac1.1 in the closed state. Science 300:1922–1926
Lafreniere RG, Rouleau GA (2011) Migraine: role of the TRESK two-pore potassium channel. Int J Biochem Cell Biol 43:1533–1536
Lafreniere RG, Cader MZ, Poulin JF, Andres-Enguix I, Simoneau M, Gupta N, Boisvert K, Lafreniere F, McLaughlan S, Dube MP et al (2010) A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med 16:1157–1160
Lancaster B, Nicoll RA (1987) Properties of two calcium-activated hyperpolarizations in rat hippocampal neurones. J Physiol 389:187–203
Larsson HP, Baker OS, Dhillon DS, Isacoff EY (1996) Transmembrane movement of the shaker K+ channel S4. Neuron 16:387–397
Latorre R, Castillo K, Carrasquel-Ursulaez W, Sepulveda RV, Gonzalez-Nilo F, Gonzalez C, Alvarez O (2017) Molecular determinants of BK channel functional diversity and functioning. Physiol Rev 97:39–87
Lee S-Y, Mackinnon R (2004) A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom. Nature 430:232–235
Lee CH, MacKinnon R (2018) Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. Science 360:508–513
Lee KPK, Chen J, MacKinnon R (2017) Molecular structure of human KATP in complex with ATP and ADP. eLife 6
Leng Q, MacGregor GG, Dong K, Giebisch G, Hebert SC (2006) Subunit-subunit interactions are critical for proton sensitivity of ROMK: evidence in support of an intermolecular gating mechanism. Proc Natl Acad Sci U S A 103:1982–1987
Lesage F, Reyes R, Fink M, Duprat F, Guillemare E, Lazdunski M (1996) Dimerization of TWIK-1 K+ channel subunits via a disulfide bridge. EMBO J 15:6400–6407
Li Q, Yan J (2016) Modulation of BK channel function by auxiliary beta and gamma subunits. Int Rev Neurobiol 128:51–90
Li Q, Zhang M, Duan Z, Stamatoyannopoulos G (1999) Structural analysis and mapping of DNase I hypersensitivity of HS5 of the beta-globin locus control region. Genomics 61:183–193
Lin MC, Hsieh JY, Mock AF, Papazian DM (2011) R1 in the shaker S4 occupies the gating charge transfer center in the resting state. J Gen Physiol 138:155–163
Liu Y, Liu D, Heath L, Meyers DM, Krafte DS, Wagoner PK, Silvia CP, Yu W, Curran ME (2001) Direct activation of an inwardly rectifying potassium channel by arachidonic acid. Mol Pharmacol 59:1061–1068
Liu S, Focke PJ, Matulef K, Bian X, Moënne-Loccoz P, Valiyaveetil FI, Lockless SW (2015) Ion-binding properties of a K + channel selectivity filter in different conformations. Proc Natl Acad Sci U S A 112:15096–15100
Logsdon NJ, Kang J, Togo JA, Christian EP, Aiyar J (1997) A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J Biol Chem 272:32723–32726
Lolicato M, Arrigoni C, Mori T, Sekioka Y, Bryant C, Clark KA, Minor DL Jr (2017) K2P2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site. Nature 547:364–368
Long SB (2005) Crystal structure of a mammalian voltage-dependent shaker family K+ channel. Science 309:897–903
Long SB, Tao X, Campbell EB, Mackinnon R (2007) Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature 450:376–382
Lopatin AN, Nichols CG (1996) [K+] dependence of open-channel conductance in cloned inward rectifier potassium channels (IRK1, Kir2.1). Biophys J 71:682–694
Lopatin AN, Makhina EN, Nichols CG (1994) Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 372:366–369
Lopatin AN, Makhina EN, Nichols CG (1995) The mechanism of inward rectification of potassium channels: “long-pore plugging” by cytoplasmic polyamines. J Gen Physiol 106:923–955
Lopes CM, Zilberberg N, Goldstein SA (2001) Block of Kcnk3 by protons. Evidence that 2-P-domain potassium channel subunits function as homodimers. J Biol Chem 276:24449–24452
Lopes CM, Rohacs T, Czirjak G, Balla T, Enyedi P, Logothetis DE (2005) PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels. J Physiol 564:117–129
Losin S, McKean CM (1966) Chlorzoxazone (paraflex) in the treatment of severe spasticity. Dev Med Child Neurol 8:768–769
Lourdel S, Paulais M, Cluzeaud F, Bens M, Tanemoto M, Kurachi Y, Vandewalle A, Teulon J (2002) An inward rectifier K(+) channel at the basolateral membrane of the mouse distal convoluted tubule: similarities with Kir4-Kir5.1 heteromeric channels. J Physiol 538:391–404
Lu Z, MacKinnon R (1994) Electrostatic tuning of Mg2+ affinity in an inward-rectifier K+ channel. Nature 371:243–246
Lu Z, MacKinnon R (1997) Purification, characterization, and synthesis of an inward-rectifier K+ channel inhibitor from scorpion venom. Biochemistry 36:6936–6940
Lunn ML, Nassirpour R, Arrabit C, Tan J, McLeod I, Arias CM, Sawchenko PE, Yates JR 3rd, Slesinger PA (2007) A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction. Nat Neurosci 10:1249–1259
Ma D, Zerangue N, Raab-Graham K, Fried SR, Jan YN, Jan LY (2002) Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart. Neuron 33:715–729
Ma Z, Lou XJ, Horrigan FT (2006) Role of charged residues in the S1-S4 voltage sensor of BK channels. J Gen Physiol 127:309–328
Ma L, Zhang X, Chen H (2011) TWIK-1 two-pore domain potassium channels change ion selectivity and conduct inward leak sodium currents in hypokalemia. Sci Signal 4:ra37
Ma L, Zhang X, Zhou M, Chen H (2012) Acid-sensitive TWIK and TASK two-pore domain potassium channels change ion selectivity and become permeable to sodium in extracellular acidification. J Biol Chem 287:37145–37153
Magidovich E, Fleishman SJ, Yifrach O (2006) Intrinsically disordered C-terminal segments of voltage-activated potassium channels: a possible fishing rod-like mechanism for channel binding to scaffold proteins. Bioinformatics 22:1546–1550
Maingret F, Lauritzen I, Patel AJ, Heurteaux C, Reyes R, Lesage F, Lazdunski M, Honore E (2000) TREK-1 is a heat-activated background K(+) channel. EMBO J 19:2483–2491
Makary SM, Claydon TW, Dibb KM, Boyett MR (2006) Base of pore loop is important for rectification, activation, permeation, and block of Kir3.1/Kir3.4. Biophys J 90:4018–4034
Manganas LN, Trimmer JS (2000) Subunit composition determines Kv1 potassium channel surface expression. J Biol Chem 275:29685–29693
Manganas LN, Wang Q, Scannevin RH, Antonucci DE, Rhodes KJ, Trimmer JS (2001) Identification of a trafficking determinant localized to the Kv1 potassium channel pore. Proc Natl Acad Sci 98:14055–14059
Mannhold R (2004) KATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev 24:213–266
Martin GM, Yoshioka C, Rex EA, Fay JF, Xie Q, Whorton MR, Chen JZ, Shyng SL (2017) Cryo-EM structure of the ATP-sensitive potassium channel illuminates mechanisms of assembly and gating. eLife 6
Matsuda H, Saigusa A, Irisawa H (1987) Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+. Nature 325:156–159
Matsuoka T, Matsushita K, Katayama Y, Fujita A, Inageda K, Tanemoto M, Inanobe A, Yamashita S, Matsuzawa Y, Kurachi Y (2000) C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels. Circ Res 87:873–880
McKeown L, Burnham MP, Hodson C, Jones OT (2008) Identification of an evolutionarily conserved extracellular threonine residue critical for surface expression and its potential coupling of adjacent voltage-sensing and gating domains in voltage-gated potassium channels. J Biol Chem 283:30421–30432
McManus OB, Helms LM, Pallanck L, Ganetzky B, Swanson R, Leonard RJ (1995) Functional role of the beta subunit of high conductance calcium-activated potassium channels. Neuron 14:645–650
Medhurst AD, Rennie G, Chapman CG, Meadows H, Duckworth MD, Kelsell RE, Gloger II, Pangalos MN (2001) Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res Mol Brain Res 86:101–114
Meera P, Wallner M, Song M, Toro L (1997) Large conductance voltage- and calcium-dependent K+ channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6), an extracellular N terminus, and an intracellular (S9-S10) C terminus. Proc Natl Acad Sci U S A 94:14066–14071
Meera P, Wallner M, Toro L (2000) A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+−activated K+ channel resistant to charybdotoxin and iberiotoxin. Proc Natl Acad Sci U S A 97:5562–5567
Meredith AL, Wiler SW, Miller BH, Takahashi JS, Fodor AA, Ruby NF, Aldrich RW (2006) BK calcium-activated potassium channels regulate circadian behavioral rhythms and pacemaker output. Nat Neurosci 9:1041–1049
Miki T, Liss B, Minami K, Shiuchi T, Saraya A, Kashima Y, Horiuchi M, Ashcroft F, Minokoshi Y, Roeper J et al (2001) ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 4:507–512
Miller C (1995) The charybdotoxin family of K+ channel-blocking peptides. Neuron 15:5–10
Miller AN, Long SB (2012) Crystal structure of the human two-pore domain potassium channel K2P1. Science 335:432–436
Miller C, Moczydlowski E, Latorre R, Phillips M (1985) Charybdotoxin, a protein inhibitor of single Ca2+−activated K+ channels from mammalian skeletal muscle. Nature 313:316–318
Mitcheson JS, Hancox JC (1999) An investigation of the role played by the E-4031-sensitive (rapid delayed rectifier) potassium current in isolated rabbit atrioventricular nodal and ventricular myocytes. Pflugers Arch 438:843–850
Montgomery JR, Whitt JP, Wright BN, Lai MH, Meredith AL (2013) Mis-expression of the BK K(+) channel disrupts suprachiasmatic nucleus circuit rhythmicity and alters clock-controlled behavior. Am J Physiol Cell Physiol 304:C299–C311
Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH (1995) ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 92:2929–2934
Muiesan G, Fariello R, Muiesan ML, Christensen OE (1985) Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension. Eur J Clin Pharmacol 28:495–499
Munoz MB, Slesinger PA (2014) Sorting nexin 27 regulation of G protein-gated inwardly rectifying K+ channels attenuates in vivo cocaine response. Neuron 82:659–669
Nesti E, Everill B, Morielli AD (2004) Endocytosis as a mechanism for tyrosine kinase-dependent suppression of a voltage-gated potassium channel. Mol Biol Cell 15:4073–4088
Nestorowicz A, Inagaki N, Gonoi T, Schoor KP, Wilson BA, Glaser B, Landau H, Stanley CA, Thornton PS, Seino S et al (1997) A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 46:1743–1748
Nichols CG, Lee SJ (2018) Polyamines and potassium channels: a 25-year romance. J Biol Chem 293:18779–18788
Niemeyer MI, Cid LP, Valenzuela X, Paeile V, Sepulveda FV (2003) Extracellular conserved cysteine forms an intersubunit disulphide bridge in the KCNK5 (TASK-2) K+ channel without having an essential effect upon activity. Mol Membr Biol 20:185–191
Niemeyer MI, Gonzalez-Nilo FD, Zuniga L, Gonzalez W, Cid LP, Sepulveda FV (2007) Neutralization of a single arginine residue gates open a two-pore domain, alkali-activated K+ channel. Proc Natl Acad Sci U S A 104:666–671
Niemeyer MI, Cid LP, Gonzalez W, Sepulveda FV (2016) Gating, regulation, and structure in K2P K+ channels: in varietate concordia? Mol Pharmacol 90:309–317
Nishida M, Cadene M, Chait BT, MacKinnon R (2007) Crystal structure of a Kir3.1-prokaryotic Kir channel chimera. EMBO J 26:4005–4015
Noble D, Tsien RW (1969a) Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres. J Physiol 200:205–231
Noble D, Tsien RW (1969b) Reconstruction of the repolarization process in cardiac Purkinje fibres based on voltage clamp measurements of membrane current. J Physiol 200:233–254
Noda M, Shimizu S, Tanabe T, Takai T, Kayano T, Ikeda T, Takahashi H, Nakayama H, Kanaoka Y, Minamino N et al (1984) Primary structure of electrophorus electricus sodium channel deduced from cDNA sequence. Nature 312:121–127
Noskov SY, Bernèche S, Roux B (2004) Control of ion selectivity in potassium channels by electrostatic and dynamic properties of carbonyl ligands. Nature 431:830–834
Oliver D, Baukrowitz T, Fakler B (2000) Polyamines as gating molecules of inward-rectifier K+ channels. Eur J Biochem 267:5824–5829
Olsen O, Liu H, Wade JB, Merot J, Welling PA (2002) Basolateral membrane expression of the Kir 2.3 channel is coordinated by PDZ interaction with Lin-7/CASK complex. Am J Physiol Cell Physiol 282:C183–C195
Oonuma H, Iwasawa K, Iida H, Nagata T, Imuta H, Morita Y, Yamamoto K, Nagai R, Omata M, Nakajima T (2002) Inward rectifier K(+) current in human bronchial smooth muscle cells: inhibition with antisense oligonucleotides targeted to Kir2.1 mRNA. Am J Respir Cell Mol Biol 26:371–379
Palygin O, Pochynyuk O, Staruschenko A (2017) Role and mechanisms of regulation of the basolateral Kir 4.1/Kir 5.1K(+) channels in the distal tubules. Acta Physiol 219:260–273
Parcej DN, Dolly JO (1989) Elegance persists in the purification of K+ channels. Biochem J 264:623–624
Patel AJ, Honore E, Lesage F, Fink M, Romey G, Lazdunski M (1999) Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci 2:422–426
Patel C, Yan GX, Antzelevitch C (2010) Short QT syndrome: from bench to bedside. Circ Arrhythm Electrophysiol 3:401–408
Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS (1995) A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet 11:126–129
Pau V, Zhou Y, Ramu Y, Xu Y, Lu Z (2017) Crystal structure of an inactivated mutant mammalian voltage-gated K+ channel. Nat Struct Mol Biol 24:857–865
Payandeh J, Scheuer T, Zheng N, Catterall WA (2011) The crystal structure of a voltage-gated sodium channel. Nature 475:353–358
Pedarzani P, D'Hoedt D, Doorty KB, Wadsworth JD, Joseph JS, Jeyaseelan K, Kini RM, Gadre SV, Sapatnekar SM, Stocker M et al (2002) Tamapin, a venom peptide from the Indian red scorpion (Mesobuthus tamulus) that targets small conductance Ca2+−activated K+ channels and afterhyperpolarization currents in central neurons. J Biol Chem 277:46101–46109
Pegan S, Arrabit C, Zhou W, Kwiatkowski W, Collins A, Slesinger PA, Choe S (2005) Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nat Neurosci 8:279–287
Pereira V, Busserolles J, Christin M, Devilliers M, Poupon L, Legha W, Alloui A, Aissouni Y, Bourinet E, Lesage F et al (2014) Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception. Pain 155:2534–2544
Pessia M, Imbrici P, D'Adamo MC, Salvatore L, Tucker SJ (2001) Differential pH sensitivity of Kir4.1 and Kir4.2 potassium channels and their modulation by heteropolymerisation with Kir5.1. J Physiol 532:359–367
Plant LD (2012) A role for K2P channels in the operation of somatosensory nociceptors. Front Mol Neurosci 5:21
Plant LD, Kemp PJ, Peers C, Henderson Z, Pearson HA (2002) Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. Stroke 33:2324–2328
Pluger S, Faulhaber J, Furstenau M, Lohn M, Waldschutz R, Gollasch M, Haller H, Luft FC, Ehmke H, Pongs O (2000) Mice with disrupted BK channel beta1 subunit gene feature abnormal ca(2+) spark/STOC coupling and elevated blood pressure. Circ Res 87:E53–E60
Pollema-Mays SL, Centeno MV, Ashford CJ, Apkarian AV, Martina M (2013) Expression of background potassium channels in rat DRG is cell-specific and down-regulated in a neuropathic pain model. Mol Cell Neurosci 57:1–9
Pongs O, Leicher T, Berger M, Roeper J, Bahring R, Wray D, Giese KP, Silva AJ, Storm JF (1999) Functional and molecular aspects of voltage-gated K+ channel beta subunits. Ann N Y Acad Sci 868:344–355
Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874
Quayle JM, McCarron JG, Brayden JE, Nelson MT (1993) Inward rectifier K+ currents in smooth muscle cells from rat resistance-sized cerebral arteries. Am J Phys 265:C1363–C1370
Rainero I, Rubino E, Gallone S, Zavarise P, Carli D, Boschi S, Fenoglio P, Savi L, Gentile S, Benna P et al (2014) KCNK18 (TRESK) genetic variants in Italian patients with migraine. Headache 54:1515–1522
Rajan S, Wischmeyer E, Xin Liu G, Preisig-Muller R, Daut J, Karschin A, Derst C (2000) TASK-3, a novel tandem pore domain acid-sensitive K+ channel. An extracellular histiding as pH sensor. J Biol Chem 275:16650–16657
Remedi MS, Koster JC (2010) K(ATP) channelopathies in the pancreas. Pflugers Arch 460:307–320
Rettig J, Heinemann SH, Wunder F, Lorra C, Parcej DN, Oliver Dolly J, Pongs O (1994) Inactivation properties of voltage-gated K+ channels altered by presence of β-subunit. Nature 369:289–294
Rhodes K, Keilbaugh S, Barrezueta N, Lopez K, Trimmer J (1995) Association and colocalization of K+ channel alpha- and beta-subunit polypeptides in rat brain. J Neurosci 15:5360–5371
Rhodes KJ, Monaghan MM, Barrezueta NX, Nawoschik S, Bekele-Arcuri Z, Matos MF, Nakahira K, Schechter LE, Trimmer JS (1996) Voltage-gated K+channel β subunits: expression and distribution of Kvβ1 and Kvβ2 in adult rat brain. J Neurosci 16:4846–4860
Rhodes KJ, Strassle BW, Monaghan MM, Bekele-Arcuri Z, Matos MF, Trimmer JS (1997) Association and colocalization of the Kvβ1 and Kvβ2 β-subunits with Kv1 α-subunits in mammalian brain K+channel complexes. J Neurosci 17:8246–8258
Rifkin RA, Moss SJ, Slesinger PA (2017) G protein-gated potassium channels: a link to drug addiction. Trends Pharmacol Sci 38:378–392
Rohacs T, Lopes CM, Jin T, Ramdya PP, Molnar Z, Logothetis DE (2003) Specificity of activation by phosphoinositides determines lipid regulation of Kir channels. Proc Natl Acad Sci U S A 100:745–750
Romanenko VG, Fang Y, Byfield F, Travis AJ, Vandenberg CA, Rothblat GH, Levitan I (2004) Cholesterol sensitivity and lipid raft targeting of Kir2.1 channels. Biophys J 87:3850–3861
Rosenhouse-Dantsker A, Sui JL, Zhao Q, Rusinova R, Rodriguez-Menchaca AA, Zhang Z, Logothetis DE (2008) A sodium-mediated structural switch that controls the sensitivity of Kir channels to PtdIns(4,5)P(2). Nat Chem Biol 4:624–631
Roux B (2005) Ion conduction and selectivity in K+ channels. Ann Rev Biophys Biomol Struct 34:153–171
Sadja R, Smadja K, Alagem N, Reuveny E (2001) Coupling Gbetagamma-dependent activation to channel opening via pore elements in inwardly rectifying potassium channels. Neuron 29:669–680
Sahoo N, Hoshi T, Heinemann SH (2014) Oxidative modulation of voltage-gated potassium channels. Antioxidants Redox Signal 21:933–952
Sandoz G, Thummler S, Duprat F, Feliciangeli S, Vinh J, Escoubas P, Guy N, Lazdunski M, Lesage F (2006) AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K(+) channels into open leak channels. EMBO J 25:5864–5872
Sandoz G, Douguet D, Chatelain F, Lazdunski M, Lesage F (2009) Extracellular acidification exerts opposite actions on TREK1 and TREK2 potassium channels via a single conserved histidine residue. Proc Natl Acad Sci U S A 106:14628–14633
Sanguinetti MC, Jiang C, Curran ME, Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299–307
Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, Hoyer J, Kohler R, Wulff H (2009) Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 75:281–295
Santos JS, Asmar-Rovira GA, Han GW, Liu W, Syeda R, Cherezov V, Baker KA, Stevens RC, Montal M (2012) Crystal structure of a voltage-gated K+channel pore module in a closed state in lipid membranes. J Biol Chem 287:43063–43070
Sausbier U, Sausbier M, Sailer CA, Arntz C, Knaus HG, Neuhuber W, Ruth P (2006) Ca2+ −activated K+ channels of the BK-type in the mouse brain. Histochem Cell Biol 125:725–741
Savarin P, Guenneugues M, Gilquin B, Lamthanh H, Gasparini S, Zinn-Justin S, Ménez A (1998) Three-dimensional structure of κ-conotoxin PVIIA, a novel potassium channel-blocking toxin from cone snails†,‡. Biochemistry 37:5407–5416
Schewe M, Nematian-Ardestani E, Sun H, Musinszki M, Cordeiro S, Bucci G, de Groot BL, Tucker SJ, Rapedius M, Baukrowitz T (2016) A non-canonical voltage-sensing mechanism controls gating in K2P K(+) channels. Cell 164:937–949
Schmid-Antomarchi H, de Weille J, Fosset M, Lazdunski M (1987) The antidiabetic sulfonylurea glibenclamide is a potent blocker of the ATP-modulated K+ channel in insulin secreting cells. Biochem Biophys Res Commun 146:21–25
Schmidt D, Mackinnon R (2008) Voltage-dependent K+ channel gating and voltage sensor toxin sensitivity depend on the mechanical state of the lipid membrane. Proc Natl Acad Sci 105:19276–19281
Schmidt D, Cross SR, Mackinnon R (2009) A gating model for the archeal voltage-dependent K+ channel KvAP in DPhPC and POPE:POPG decane lipid bilayers. J Mol Biol 390:902–912
Scholl UI, Choi M, Liu T, Ramaekers VT, Hausler MG, Grimmer J, Tobe SW, Farhi A, Nelson-Williams C, Lifton RP (2009) Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci U S A 106:5842–5847
Schreiber M, Salkoff L (1997) A novel calcium-sensing domain in the BK channel. Biophys J 73:1355–1363
Schulte U, Fakler B (2000) Gating of inward-rectifier K+ channels by intracellular pH. Eur J Biochem 267:5837–5841
Schulte U, Thumfart JO, Klocker N, Sailer CA, Bildl W, Biniossek M, Dehn D, Deller T, Eble S, Abbass K et al (2006) The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 49:697–706
Schumacher MA, Rivard AF, Bachinger HP, Adelman JP (2001) Structure of the gating domain of a Ca2+−activated K+ channel complexed with Ca2+/calmodulin. Nature 410:1120–1124
Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT et al (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89–95
Sforna L, Megaro A, Pessia M, Franciolini F, Catacuzzeno L (2018) Structure, gating and basic functions of the Ca2+−activated K channel of intermediate conductance. Curr Neuropharmacol 16:608–617
Shen KZ, Lagrutta A, Davies NW, Standen NB, Adelman JP, North RA (1994) Tetraethylammonium block of slowpoke calcium-activated potassium channels expressed in Xenopus oocytes: evidence for tetrameric channel formation. Pflugers Arch 426:440–445
Shi J, Cui J (2001) Intracellular mg(2+) enhances the function of BK-type ca(2+)-activated K(+) channels. J Gen Physiol 118:589–606
Shi J, He HQ, Zhao R, Duan YH, Chen J, Chen Y, Yang J, Zhang JW, Shu XQ, Zheng P et al (2008) Inhibition of martentoxin on neuronal BK channel subtype (alpha+beta4): implications for a novel interaction model. Biophys J 94:3706–3713
Shibasaki T (1987) Conductance and kinetics of delayed rectifier potassium channels in nodal cells of the rabbit heart. J Physiol 387:227–250
Shimizu W, Antzelevitch C (2000) Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 35:778–786
Shin N, Soh H, Chang S, Kim DH, Park CS (2005) Sodium permeability of a cloned small-conductance calcium-activated potassium channel. Biophys J 89:3111–3119
Shrivastava IH, Peter Tieleman D, Biggin PC, Sansom MSP (2002) K+ versus Na+ ions in a K channel selectivity filter: a simulation study. Biophys J 83:633–645
Shumilina E, Klocker N, Korniychuk G, Rapedius M, Lang F, Baukrowitz T (2006) Cytoplasmic accumulation of long-chain coenzyme A esters activates KATP and inhibits Kir2.1 channels. J Physiol 575:433–442
Shyng S, Nichols CG (1997) Octameric stoichiometry of the KATP channel complex. J Gen Physiol 110:655–664
Singh S, Syme CA, Singh AK, Devor DC, Bridges RJ (2001) Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. J Pharmacol Exp Ther 296:600–611
Singh AK, McMillan J, Bukiya AN, Burton B, Parrill AL, Dopico AM (2012) Multiple cholesterol recognition/interaction amino acid consensus (CRAC) motifs in cytosolic C tail of Slo1 subunit determine cholesterol sensitivity of Ca2+− and voltage-gated K+ (BK) channels. J Biol Chem 287:20509–20521
Slesinger PA, Patil N, Liao YJ, Jan YN, Jan LY, Cox DR (1996) Functional effects of the mouse weaver mutation on G protein-gated inwardly rectifying K+ channels. Neuron 16:321–331
Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, Schwartzkroin PA, Messing A, Tempel BL (1998) Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 20:809–819
Smith PL, Baukrowitz T, Yellen G (1996) The inward rectification mechanism of the HERG cardiac potassium channel. Nature 379:833–836
Smith SEP, Xu L, Kasten MR, Anderson MP (2012) Mutant LGI1 inhibits seizure-induced trafficking of Kv4.2 potassium channels. J Neurochem 120:611–621
Srinivasan KN, Sivaraja V, Huys I, Sasaki T, Cheng B, Kumar TKS, Sato K, Tytgat J, Yu C, San BCC et al (2002) κ-Hefutoxin1, a novel toxin from the scorpionheterometrus fulvipes with unique structure and function. J Biol Chem 277:30040–30047
Stanfield PR, Davies NW, Shelton PA, Sutcliffe MJ, Khan IA, Brammar WJ, Conley EC (1994) A single aspartate residue is involved in both intrinsic gating and blockage by Mg2+ of the inward rectifier, IRK1. J Physiol 478(Pt 1):1–6
Storm JF (1987) Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells. J Physiol 385:733–759
Strassmaier T, Bond CT, Sailer CA, Knaus HG, Maylie J, Adelman JP (2005) A novel isoform of SK2 assembles with other SK subunits in mouse brain. J Biol Chem 280:21231–21236
Strobaek D, Christophersen P, Holm NR, Moldt P, Ahring PK, Johansen TE, Olesen SP (1996) Modulation of the ca(2+)-dependent K+ channel, hslo, by the substituted diphenylurea NS 1608, paxilline and internal Ca2+. Neuropharmacology 35:903–914
Strobaek D, Jorgensen TD, Christophersen P, Ahring PK, Olesen SP (2000) Pharmacological characterization of small-conductance ca(2+)-activated K(+) channels stably expressed in HEK 293 cells. Br J Pharmacol 129:991–999
Strobaek D, Teuber L, Jorgensen TD, Ahring PK, Kjaer K, Hansen RS, Olesen SP, Christophersen P, Skaaning-Jensen B (2004) Activation of human IK and SK Ca2+ −activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). Biochim Biophys Acta 1665:1–5
Strobaek D, Hougaard C, Johansen TH, Sorensen US, Nielsen EO, Nielsen KS, Taylor RD, Pedarzani P, Christophersen P (2006) Inhibitory gating modulation of small conductance Ca2+−activated K+ channels by the synthetic compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reduces afterhyperpolarizing current in hippocampal CA1 neurons. Mol Pharmacol 70:1771–1782
Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marban E, Nakaya H (2002) Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 109:509–516
Syeda R, Santos JS, Montal M (2014) Lipid bilayer modules as determinants of K+channel gating. J Biol Chem 289:4233–4243
Tabcharani JA, Misler S (1989) Ca2+-activated K+ channel in rat pancreatic islet B cells: permeation, gating and blockade by cations. Biochim Biophys Acta 982:62–72
Taglialatela M, Ficker E, Wible BA, Brown AM (1995) C-terminus determinants for Mg2+ and polyamine block of the inward rectifier K+ channel IRK1. EMBO J 14:5532–5541
Takahira M, Sakurai M, Sakurada N, Sugiyama K (2005) Fenamates and diltiazem modulate lipid-sensitive mechano-gated 2P domain K(+) channels. Pflügers Arch 451:474–478
Takenaka K, Ai T, Shimizu W, Kobori A, Ninomiya T, Otani H, Kubota T, Takaki H, Kamakura S, Horie M (2003) Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 107:838–844
Talley EM, Lei Q, Sirois JE, Bayliss DA (2000) TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons. Neuron 25:399–410
Tanemoto M, Kittaka N, Inanobe A, Kurachi Y (2000) In vivo formation of a proton-sensitive K+ channel by heteromeric subunit assembly of Kir5.1 with Kir4.1. J Physiol 525(Pt 3):587–592
Tanemoto M, Abe T, Ito S (2005) PDZ-binding and di-hydrophobic motifs regulate distribution of Kir4.1 channels in renal cells. J Am Soc Nephrol 16:2608–2614
Tao X, MacKinnon R (2019) Molecular structures of the human Slo1 K(+) channel in complex with beta4. eLife 8
Tao X, Hite RK, MacKinnon R (2017) Cryo-EM structure of the open high-conductance ca(2+)-activated K(+) channel. Nature 541:46–51
Teichert RW, Schmidt EW, Olivera BM (2015) Constellation pharmacology: a new paradigm for drug discovery. Ann Rev Pharmacol Toxicol 55:573–589
Terzic A, Jahangir A, Kurachi Y (1995) Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs. Am J Phys 269:C525–C545
Tian Y, Ullrich F, Xu R, Heinemann SH, Hou S, Hoshi T (2015) Two distinct effects of PIP2 underlie auxiliary subunit-dependent modulation of Slo1 BK channels. J Gen Physiol 145:331–343
Tinker A, Aziz Q, Li Y, Specterman M (2018) ATP-sensitive potassium channels and their physiological and pathophysiological roles. Compr Physiol 8:1463–1511
Tong Y, Wei J, Zhang S, Strong JA, Dlouhy SR, Hodes ME, Ghetti B, Yu L (1996) The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2. FEBS Lett 390:63–68
Trimmer JS, Rhodes KJ (2004) Localization of voltage-gated ion channels in mammalian brain. Annu Rev Physiol 66:477–519
Tucker SJ, Imbrici P, Salvatore L, D’Adamo MC, Pessia M (2000) pH dependence of the inwardly rectifying potassium channel, Kir5.1, and localization in renal tubular epithelia. J Biol Chem 275:16404–16407
Tudor JE, Pallaghy PK, Pennington MW, Norton RS (1996) Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone. Nat Struct Biol 3:317–320
Tulleuda A, Cokic B, Callejo G, Saiani B, Serra J, Gasull X (2011) TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury. Mol Pain 7:30
Turner KL, Honasoge A, Robert SM, McFerrin MM, Sontheimer H (2014) A proinvasive role for the ca(2+) -activated K(+) channel KCa3.1 in malignant glioma. Glia 62:971–981
Uebele VN, Lagrutta A, Wade T, Figueroa DJ, Liu Y, McKenna E, Austin CP, Bennett PB, Swanson R (2000) Cloning and functional expression of two families of beta-subunits of the large conductance calcium-activated K+ channel. J Biol Chem 275:23211–23218
Vacher H, Mohapatra DP, Misonou H, Trimmer JS (2007) Regulation of Kvl channel trafficking by the mamba snake neurotoxin dendrotoxin K. FASEB J 21:906–914
Vacher H, Mohapatra DP, Trimmer JS (2008) Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol Rev 88:1407–1447
Valiyaveetil FI, Zhou Y, Mackinnon R (2002) Lipids in the structure, folding, and function of the KcsA K+channel. Biochemistry 41:10771–10777
Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, Latorre R (1999) Acute activation of maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 285:1929–1931
Van Dalen A, De Kruijff B (2004) The role of lipids in membrane insertion and translocation of bacterial proteins. Biochim Biophys Acta (BBA) Mol Cell Res 1694:97–109
Van Wart A, Trimmer JS, Matthews G (2007) Polarized distribution of ion channels within microdomains of the axon initial segment. J Comp Neurol 500:339–352
Vandorpe DH, Shmukler BE, Jiang L, Lim B, Maylie J, Adelman JP, de Franceschi L, Cappellini MD, Brugnara C, Alper SL (1998) cDNA cloning and functional characterization of the mouse Ca2+−gated K+ channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J Biol Chem 273:21542–21553
Varma S, Rogers DM, Pratt LR, Rempe SB (2011) Design principles for K+ selectivity in membrane transport. J Gen Physiol 137:479–488
Veale EL, Al-Moubarak E, Bajaria N, Omoto K, Cao L, Tucker SJ, Stevens EB, Mathie A (2014) Influence of the N terminus on the biophysical properties and pharmacology of TREK1 potassium channels. Mol Pharmacol 85:671–681
Villarroel A, Alvarez O, Oberhauser A, Latorre R (1988) Probing a Ca2+−activated K+ channel with quaternary ammonium ions. Pflugers Arch 413:118–126
Wallner M, Meera P, Toro L (1999) Molecular basis of fast inactivation in voltage and Ca2+−activated K+ channels: a transmembrane beta-subunit homolog. Proc Natl Acad Sci U S A 96:4137–4142
Walsh KB (2020) Screening technologies for inward rectifier potassium channels: discovery of new blockers and activators. SLAS Discov 25:420–433
Wang YW, Ding JP, Xia XM, Lingle CJ (2002) Consequences of the stoichiometry of Slo1 alpha and auxiliary beta subunits on functional properties of large-conductance Ca2+−activated K+ channels. J Neurosci 22:1550–1561
Wang B, Rothberg BS, Brenner R (2006) Mechanism of beta4 subunit modulation of BK channels. J Gen Physiol 127:449–465
Weatherall KL, Goodchild SJ, Jane DE, Marrion NV (2010) Small conductance calcium-activated potassium channels: from structure to function. Prog Neurobiol 91:242–255
Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H (2005) International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 57:463–472
Weiger TM, Holmqvist MH, Levitan IB, Clark FT, Sprague S, Huang WJ, Ge P, Wang C, Lawson D, Jurman ME et al (2000) A novel nervous system beta subunit that downregulates human large conductance calcium-dependent potassium channels. J Neurosci 20:3563–3570
Weik R, Neumcke B (1989) ATP-sensitive potassium channels in adult mouse skeletal muscle: characterization of the ATP-binding site. J Membr Biol 110:217–226
Welling PA (2016) Roles and regulation of renal K channels. Annu Rev Physiol 78:415–435
Whitt JP, Montgomery JR, Meredith AL (2016) BK channel inactivation gates daytime excitability in the circadian clock. Nat Commun 7:10837
Whorton MR, MacKinnon R (2011) Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium. Cell 147:199–208
Whorton MR, MacKinnon R (2013) X-ray structure of the mammalian GIRK2-betagamma G-protein complex. Nature 498:190–197
Wible BA, Taglialatela M, Ficker E, Brown AM (1994) Gating of inwardly rectifying K+ channels localized to a single negatively charged residue. Nature 371:246–249
Wilke BU, Lindner M, Greifenberg L, Albus A, Kronimus Y, Bunemann M, Leitner MG, Oliver D (2014) Diacylglycerol mediates regulation of TASK potassium channels by Gq-coupled receptors. Nat Commun 5:5540
Wischmeyer E, Doring F, Karschin A (2000) Stable cation coordination at a single outer pore residue defines permeation properties in Kir channels. FEBS Lett 466:115–120
Woo DH, Han KS, Shim JW, Yoon BE, Kim E, Bae JY, Oh SJ, Hwang EM, Marmorstein AD, Bae YC et al (2012) TREK-1 and Best1 channels mediate fast and slow glutamate release in astrocytes upon GPCR activation. Cell 151:25–40
Wu ZZ, Li DP, Chen SR, Pan HL (2009) Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit. J Biol Chem 284:36453–36461
Wu W, Wang Y, Deng XL, Sun HY, Li GR (2013) Cholesterol down-regulates BK channels stably expressed in HEK 293 cells. PLoS One 8:e79952
Wulff H, Castle NA (2010) Therapeutic potential of KCa3.1 blockers: recent advances and promising trends. Expert Rev Clin Pharmacol 3:385–396
Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG (2000) Design of a potent and selective inhibitor of the intermediate-conductance Ca2+−activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 97:8151–8156
Wulff H, Castle NA, Pardo LA (2009) Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 8:982–1001
Wydeven N, Marron Fernandez de Velasco E, Du Y, Benneyworth MA, Hearing MC, Fischer RA, Thomas MJ, Weaver CD, Wickman K (2014) Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297. Proc Natl Acad Sci U S A 111:10755–10760
Xia XM, Fakler B, Rivard A, Wayman G, Johnson-Pais T, Keen JE, Ishii T, Hirschberg B, Bond CT, Lutsenko S et al (1998) Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 395:503–507
Xia XM, Ding JP, Lingle CJ (1999) Molecular basis for the inactivation of Ca2+− and voltage-dependent BK channels in adrenal chromaffin cells and rat insulinoma tumor cells. J Neurosci 19:5255–5264
Xia XM, Zeng X, Lingle CJ (2002) Multiple regulatory sites in large-conductance calcium-activated potassium channels. Nature 418:880–884
Xia XM, Ding JP, Lingle CJ (2003) Inactivation of BK channels by the NH2 terminus of the beta2 auxiliary subunit: an essential role of a terminal peptide segment of three hydrophobic residues. J Gen Physiol 121:125–148
Yan J, Aldrich RW (2010) LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium. Nature 466:513–516
Yan J, Aldrich RW (2012) BK potassium channel modulation by leucine-rich repeat-containing proteins. Proc Natl Acad Sci U S A 109:7917–7922
Yang T, Snyders DJ, Roden DM (1995) Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects. Circulation 91:1799–1806
Yang JW, Vacher H, Park KS, Clark E, Trimmer JS (2007) Trafficking-dependent phosphorylation of Kv1.2 regulates voltage-gated potassium channel cell surface expression. Proc Natl Acad Sci 104:20055–20060
Yang H, Shi J, Zhang G, Yang J, Delaloye K, Cui J (2008) Activation of Slo1 BK channels by Mg2+ coordinated between the voltage sensor and RCK1 domains. Nat Struct Mol Biol 15:1152–1159
Yao J, Chen X, Li H, Zhou Y, Yao L, Wu G, Chen X, Zhang N, Zhou Z, Xu T et al (2005) BmP09, a “long chain” scorpion peptide blocker of BK channels. J Biol Chem 280:14819–14828
Yazejian B, Sun XP, Grinnell AD (2000) Tracking presynaptic Ca2+ dynamics during neurotransmitter release with Ca2+−activated K+ channels. Nat Neurosci 3:566–571
Yi BA, Lin YF, Jan YN, Jan LY (2001) Yeast screen for constitutively active mutant G protein-activated potassium channels. Neuron 29:657–667
Yoo D, Flagg TP, Olsen O, Raghuram V, Foskett JK, Welling PA (2004) Assembly and trafficking of a multiprotein ROMK (Kir 1.1) channel complex by PDZ interactions. J Biol Chem 279:6863–6873
Yu FH, Catterall WA (2004) The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Sci Signal 2004:re15
Yuan Y, Shimura M, Hughes BA (2003) Regulation of inwardly rectifying K+ channels in retinal pigment epithelial cells by intracellular pH. J Physiol 549:429–438
Yuan P, Leonetti MD, Pico AR, Hsiung Y, MacKinnon R (2010) Structure of the human BK channel Ca2+−activation apparatus at 3.0 A resolution. Science 329:182–186
Yuan P, Leonetti MD, Hsiung Y, MacKinnon R (2011) Open structure of the Ca2+ gating ring in the high-conductance Ca2+−activated K+ channel. Nature 481:94–97
Zaydman MA, Cui J (2014) PIP2 regulation of KCNQ channels: biophysical and molecular mechanisms for lipid modulation of voltage-dependent gating. Front Physiol 5:195
Zeng XH, Xia XM, Lingle CJ (2003) Redox-sensitive extracellular gates formed by auxiliary beta subunits of calcium-activated potassium channels. Nat Struct Biol 10:448–454
Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, Shen J, Splawski I, Priori SG, Compton SJ et al (2000) Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 102:2849–2855
Zhang YH, Colenso CK, Sessions RB, Dempsey CE, Hancox JC (2011) The hERG K+ channel S4 domain L532P mutation: characterization at 37°C. Biochim Biophys Acta (BBA) Biomembr 1808:2477–2487
Zhang M, Meng XY, Cui M, Pascal JM, Logothetis DE, Zhang JF (2014) Selective phosphorylation modulates the PIP2 sensitivity of the CaM-SK channel complex. Nat Chem Biol 10:753–759
Zhao Y, Ung PM, Zahoranszky-Kohalmi G, Zakharov AV, Martinez NJ, Simeonov A, Glaaser IW, Rai G, Schlessinger A, Marugan JJ et al (2020) Identification of a G-protein-independent activator of GIRK channels. Cell Rep 31:107770
Zhou M, Morais-Cabral JH, Mann S, Mackinnon R (2001a) Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature 411:657–661
Zhou Y, Morais-Cabral JH, Kaufman A, Mackinnon R (2001b) Chemistry of ion coordination and hydration revealed by a K+ channel–fab complex at 2.0 Å resolution. Nature 414:43–48
Zhou J, Chen H, Yang C, Zhong J, He W, Xiong Q (2017) Reversal of TRESK downregulation alleviates neuropathic pain by inhibiting activation of gliocytes in the spinal cord. Neurochem Res 42:1288–1298
Zhu G, Chanchevalap S, Cui N, Jiang C (1999) Effects of intra- and extracellular acidifications on single channel Kir2.3 currents. J Physiol 516(Pt 3):699–710
Zhu J, Watanabe I, Gomez B, Thornhill WB (2001) Determinants involved in Kv1 potassium channel folding in the endoplasmic reticulum, glycosylation in the golgi, and cell surface expression. J Biol Chem 276:39419–39427
Zuberi SM, Eunson LH, Spauschus A, De Silva R, Tolmie J, Wood NW, McWilliam RC, Stephenson JB, Kullmann DM, Hanna MG (1999) A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122(Pt 5):817–825
Zuniga L, Marquez V, Gonzalez-Nilo FD, Chipot C, Cid LP, Sepulveda FV, Niemeyer MI (2011) Gating of a pH-sensitive K(2P) potassium channel by an electrostatic effect of basic sensor residues on the selectivity filter. PLoS One 6:e16141
Acknowledgements
Figures created with BioRender.com
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Taura, J., Kircher, D.M., Gameiro-Ros, I., Slesinger, P.A. (2021). Comparison of K+ Channel Families. In: Gamper, N., Wang, K. (eds) Pharmacology of Potassium Channels. Handbook of Experimental Pharmacology, vol 267. Springer, Cham. https://doi.org/10.1007/164_2021_460
Download citation
DOI: https://doi.org/10.1007/164_2021_460
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84051-8
Online ISBN: 978-3-030-84052-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)